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ABBREVIATIONS: 
 
αMHC     αMHC 
β-AR     beta adrenergic receptor 
AM     Acetoxy-Methyl-ester 
AP     Action Potential   
Bpm     Beat per minute 
cAMP     Cyclic Adenosine Monophosphate 
CFP     Cyan Fluorescent Protein   
CM     Cardyomyocytes 
ChR     Channelrhodopsin 
CICR     Calcium Induced Calcium Release 
CPVT Catecholaminergic Polymorfic Ventricular 
Tachycardia 
DAD Delayed after depolarization 
EAD Early after Depolarization 
ECG  Electrocardiogram  
EM  Electron Microscopy 
HS     Horse Serum     
HR     Heart Rate 
ID     Intercalated Disk 
NCS     New Calf Serum 
NCX     Na+/Ca2+ Exchanger 
NE     Norepinephrine 
NGF     Nerve Growth Factor 
PBS     Polyphosphate Saline Buffer 
PCR     Polimerase Chain Reaction                                              
PDE     PhophoDiesterase 
PFA     ParaFormAldeide 
PKA     Protein Kinase A 
PNS     Parasympathetic Nervous System 
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Po   Open Probabiliy 
RyR2   Ryanodine Receptor 2 
SERCA    Sarco-Endoplasmic Reticulum Ca2+ ATPase 
SN     Sympathetic Neurons 
SNS     Sympathetic Nervous System 
SR     Sarcoplasmatic Reticulum 
TAE     Tris-Acetate-EDTA 
YFP     Yellow Fluorescent Protein   
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SUMMARY 
 
The heart is densely innervated by sympathetic neurons (SN) that regulate cardiac function 
both through chronotropic and inotropic effects. During exercise and stress, SN-released 
norepinephrine activates cardiac beta adrenergic receptors (β-ARs) on both the conduction 
and contractile systems. Increased cardiac sympathetic activity leads to arrhythmias in 
acquired (e.g. myocardial ischemia) or inherited conditions, including Catecholaminergic 
Polymorphic Ventricular Tachycardia (CPVT), possibly via development of Ca2+ 
overload-dependent early- or delayed-afterdepolarizations (EAD, DAD, respectively).  
The DAD would serve as arrhythmogenic focus, leading to the onset of triggered activity 
in discrete groups of cardiac cells. Unbalanced sympathetic discharge to different regions 
of the heart has been identified as a potent arrhythmogenic condition [1]. In addition to the 
direct cardiomyocyte damage, alteration in presynaptic NE reuptake from the autonomic 
neuron endings, leading to catecholamine spillover in the failing myocardium [2], 
inducing is an arrhythmic event. These data support a model in which autonomic control 
of cardiac function relies on specialized sites of direct interaction between the neurons and 
their target cardiomyocytes (CM).  
The aims of the project are: 
 
1. To investigate whether specific cell-cell interactions have a role in the dynamics of 
intercellular signaling between SN and CM, aims to understand how unbalanced SN 
activity leads to arrhythmic condition. 
 
2. To understand whether the unbalanced SN modulation of a limited group of cardiac 
cells could be involved in generating arrhythmias in vivo, based on an optogenetic 
approach 
 
3. To study in vivo, non-invasively, the critical mass of myocardium necessary to generate 
an arrhythmogenic focus, using optogenetics. 
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In the first part of the project, we used an in vitro model of sympathetic 
neurons/cardiomyocytes (SN-CM) co-cultures to analyze the dynamics of intercellular 
signaling. Upon NGF treatment, SNs extend their axons and establish direct contact with 
CMs. NE-synthesizing terminals developed on SN at the contact site, and β1-ARs were 
enriched on the CM membrane in correspondence of the active release areas [3]. We 
performed real-time imaging using the FRET-based biosensors EPAC1-camps and 
AKAR3 to assess intracellular cAMP and PKA activity, respectively. Stimulation of SN 
was achieved using KCl or bradykinin. We observed that activation of a specific SN lead 
to cAMP increase in the interacting CM (∆R/R0 = 5.6% ± 1% mean ± SEM, n = 8, 
AKAR3 ∆R/R0= 5.3% ± 1.5%, mean ± SEM, n=6). The cAMP response in 
cardiomyocytes was not due to NE released in the medium, and was absent in cells not in 
direct contact with the activated neuron. We showed that in cells without SN coupled the 
intracellular cAMP and PKA activity were not affected.  
To estimate the [NE] acting on the CM β-AR at the contact site, we compared the 
amplitude of the FRET signal evoked by SN activation (∆R/R0=  2.6 % ± 0.6%, mean  ± 
SEM, n=13 ) to that elicited by different [NE] administered to the cell bathing solution, 
and we observed that the increase in the CFP/YFP ratio achieved by SN-released NE is 
comparable to that obtained with 3.5e-10 M NE to whole cell. Using the competitive β-
antagonist propranolol we determined the effective [NE] in the ‘synaptic’ cleft. 
Competition antagonism of neuronal stimulation to CM was obtained with [Propranolol] 
equal to that antagonizing 100 nM of NE, indicating that such concentration is achieved in 
the ‘synaptic cleft’. Moreover, by calculating the fraction of occupancy of the receptor at 
different concentration of NE we calculated that the fraction of β-ARs activated by the 
SN-released NE is < 1%.   
 
2. In the second part of the project we used an optogenetic-based strategy to modulate 
cardiac sympathetic neurons activity non invasively in vivo. ChR2 is a light-gated cation 
channel that becomes permeable mainly to Na+ upon light-stimulation, shown to enable 
control of neuronal activity both in vitro and in the intact brain. 
We generated a mouse model expressing ChR2 in SN under the tyrosine hydroxilase 
(TOH) promoter. Photostimulation of the stellate ganglia neurons (SGN) was obtained in 
an anesthetized, open-chest model using a fiber optic to locally (1mm) deliver light 
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(470nm) generated from a LED. ECG recording demonstrates a rapid (100-150 ms) 
increase (40%±6%) in heart rate (HR) upon SGN stimulation. The extremely short 
activation time of the cardiac response upon ChR2 depolarization of the neurons support a 
model in which NE acts in a short range, consistent with direct interaction between SN 
and CM.  
 
3. We used ChR2 to modulate cardiac electrophysiology. We determined in cultured 
neonatal cardiomyocytes that photostimulation allows triggering action potential (AP). 
Moreover depending on when the light pulses were given we generated normal AP, early- 
or delayed-aferdepolarizations (EAD or DAD). We generated a mouse model with cardiac 
expression of ChR2, driven by the α-MHC promoter. Optical control of cardiomyocyte 
membrane potential was obtained with a fiber optic, while recording the ECG in the 
anesthesized mouse. Stimulation was applied to different regions of the heart. Atrial 
illumination was used to obtain non-invasive atrial pacing resulting in tachycardia with 
unchanged QRS, indicating as expected that the cardiac activation wave followed the 
natural conduction system. Ventricular photoactivation, on the contrary, bypassing the 
natural conduction system gave rise to premature ventricular beats.  
 
We provide evidence of the existence of a ‘synaptic’ contact between SN and CM that 
forms a high agonist concentration, diffusion-restricted space allowing potent activation of 
a small fraction of β-ARs on the CM membrane upon neuronal stimulation. SN 
stimulation leads to a rapid increase of the HR supporting the idea of the existence of the 
synaptic contact between SN and CM. 
This close interaction has the potential of fast control of local CM signalling, suggesting 
that SNs control locally discrete groups of myocardial cells. Stimulation of a small 
fraction of the cardiac cells (< 200 µm-wide area) induced ectopic beats conducted to the 
whole heart. 
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RIASSUNTO 
 
Il cuore è densamente innervato dai neuroni del sistema nervoso simpatico che regolano la 
funzionalità cardiaca attraverso un effetto cronotropo o inotropo positivi. Durante lo stress 
o l’esercizio, la noradrenalina rilasciata dai neuroni attiva i β recettori cardiaci sia sul 
sistema di conduzione che sul muscolo contrattile.  L’aumento dell’attività del sistema 
nervoso simpatico cardiaco sia in condizioni normali o in presenza di patologie genetiche, 
come per esempio la Tachicardia Catecolaminergica Polimorfica Ventricolare, porta ad 
aritmie presumibilmente attraverso l’insorgere di ‘DADs’. Le ‘DADs’ sono un focus di 
aritmia che porta a una serie di depolarizzazioni che interessano un piccolo gruppo di 
cellule cardiache. E’ stato identificato un rilascio di catecolamine non bilanciato in 
diverese regioni del cuore da parte del sistema nervoso simpatico come possibile causa di 
aritmia. Inoltre alterazioni del ‘reuptake’ di noradrenalina porta a una concentrazione 
anomala di NE nello scompenso cardiaco che può essere coinvolto in un evento aritmico. 
Questi dati supportano un modello in cui il controllo della funzionalità cardiaca da parte 
del sistema nervoso simpatico avviene attraverso un sito d’interazione diretta e 
specializzata fra  neurone e cardiomiocita accoppiato. 
Gli scopi del progetto sono quindi: 
 
1. Studiare se l’interazione fra neurone e cardiomiocita ha un ruolo nella trasmissione 
cardiaca del segnale, per capire come un’attività non bilanciata del sistema nervoso 
simpatico porta a un evento aritmico. 
 
2. Capire se l’attività non bilanciata del sistema nervoso simpatico modulando 
l’attività di un piccolo gruppo di cellule cardiache, possa essere coinvolto nella 
generazione di un’aritmia in vivo. Per verificare quest’ipotesi ci serviremo di un 
approccio innovativo basato su proteine foto attivabili. 
 
3. Studiare in vivo e in maniera non invasiva la massa critica di cellule cardiache 
necessaria per scatenare un evento aritmico. Anche per questo tipo di studio 
abbiamo utilizzato una metodologia basata sull’optogenetica.  
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Nella prima parte del progetto, abbiamo creato un modello in vitro costituito da 
cardiomiociti neonatali e neuroni isolati dal ganglio cervicale superiore. I neuroni in 
seguito a trattamento con NGF sviluppano assoni che stabiliscono contatti con i 
cardiomiociti. Sotto terminali che sono in contatto con le cellule cardiache si osserva un 
maggiore accumulo di β1 recettori [3].   
Abbiamo misurato l’attivazione dei β recettori monitorando in tempo reale le variazioni di 
AMP ciclico e attività di PKA, attraverso l’uso di sensori geneticamente codificati e che si 
basano sul FRET (EPAC1-camps, che ci permette di monitorare cAMP e AKAR3 che ci 
permette di monitorare l’attività di PKA). I neuroni del SNS sono stati stimolati con KCl o 
bradichinina. Abbiamo osservato che stimolando il rilascio di noradrenalina da un neurone, 
l’AMP ciclico e l’attività di PKA aumentano solo nei cardiomiociti accoppiati a neurone e 
non nei cardiomiociti senza un contatto (∆R/R0 = 0.056 ± 0.01 mean ± SEM, n = 8, 
AKAR3 ∆R/R0=5.3% ± 1.5%, mean ± SEM, n=6).  
Per stimare la [NE] che agisce sui β recettori nel sito di contatto abbiamo paragonato 
l’ampiezza del segnale FRET generato dall’attivazione neuronale (∆R/R0= 0.026 ± SEM) 
con quello generato da diverse [NE] note aggiunte alla soluzione in cui si trovano le 
cellule. Abbiamo osservato che l’aumento del rapporto CFP/YFP ottenuto dalla 
noradrenalina rilasciata dai neuroni e paragonabile a quello ottenuto con 3.5e-10 M di 
noradrenalina che attiva tutti i recettori.  
Usando un antagonista competitivo dei β recettori (propranololo) abbiamo determinato la 
concentrazione di noradrenalina nel cleft sinaptico. La concentrazione di propranolol 
necessaria per abolire totalmente la risposta indotta dalla noradrenalina rilasciata dai 
neuroni, e pari a quella necessaria per bloccare la risposta indotta da 100 nM di 
noradrenalina, suggerendo che la concentrazione nel cleft sinaptico è dell’ordine di 100 
nM. Sulla base di questi dati abbiamo quindi calcolato che la frazione recettoriale con cui 
interagisce la noradrenalina rilasciata dai neuroni che è inferiore all’1% del totale. 
 
2. Nella seconda parte del progetto abbiamo usato una strategia che si basa 
sull’‘optogenetica’ per modulare l’attività del sistema nervoso simpatico in vivo e 
in maniera non invasiva. ChR2 è un canale la cui permeabilità è regolata dalla luce. 
Infatti questo canale diventa permeabile soprattutto al Na+ in seguito a 
stimolazione con luce blu. Negli ultimi anni è stato largamente utilizzato per il 
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controllo dell’attività neuronale sia in vitro che in vivo [4, 5]. Abbiamo generato un 
modello murino che esprime ChR2 nei neuroni del sistema nervoso simpatico sotto 
il promotore tirosina idrossilasi. La foto stimolazione del ganglio stellato è stata 
ottenuta in un modello a ‘torace aperto’ di topo anestetizzato, usando una fibra 
ottica per indirizzare in uno specifico punto la luce generata da un LED. L’analisi 
dell’ECG del topo mostra un rapido (100-150 ms) aumento (40%±6%) nella 
frequenza di contrazione cardiaca in seguito a ‘fotostimolazione’ del ganglio 
stellato. Questo rapido aumento nella frequenza cardiaca supporta il modello in cui 
la noradrenalina agisce in uno spazio piccolo e confinato in cui neurone e 
cardiomiocita interagisccono direttamente. 
 
3. Abbiamo usato ChR2 anche per modulare l’elettrofisiologia cardiaca. Abbiamo 
determinato che la fotostimolazione di ChR2 è sufficiente a modulare il potenziale 
d’azione in cardiomiociti neonatali in cultura. Inoltre a seconda di quando viene 
dato il pulso di luce siamo in grado di generare un battito normale, una DAD o una 
EAD. Abbiamo quindi generato un modello di topo che esprima ChR2 nel cuore 
sotto il promotore α-MHC. Abbiamo controllato tramite stimolazione luminosa il 
potenziale d’azione di cellule cardiache utilizzando fibre ottiche alimentate da LED, 
durante l’acquisizione dell’ECG del topo. La stimolazione è stata eseguita in 
diverse regioni del cuore.  
La stimolazione atriale ci ha permesso di mimare un pacing atriale sfociato poi una 
tachicardia. Abbiamo osservato che il QRS non ha variazioni rispetto al normale, 
indicando che l’onda di depolarizzazione segue il sistema di conduzione cardiaco. 
La foto attivazione ventricolare invece genera un battito prematuro dato che non 
segue il sistema di conduzione. 
 
Abbiamo qui dimostrato l’esistenza di un contatto sinaptico fra i neuroni e i cardiomiociti 
che forma un sito a elevata concentrazione di neurotrasmettitore, uno spazio a diffusione 
limitata permettendo quindi l’attivazione di un ristretto gruppo di recettori β localizzati 
nella membrana della cellula cardiaca.  
La stimolazione neuronale genera un rapido aumento nella frequenza cardiaca 
avvalorando l’ipotesi dell’esistenza di un contatto sinaptico fra neuroni e cardiomiociti. 
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Questa interazione è importante per un controllo rapido del segnale locale dei 
cardiomiociti, suggerendo che i neuroni controllino un gruppo ristretto di cellule cardiache.  
La stimolazione di una frazione di cardiomiociti è sufficiente a indurre un battito condotto 
in tutto il cuore. 
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SYMPATHETIC NERVOUS SYSTEM IN THE HEALTHY AND DISEASED 
HEART: EVIDENCE OF A SYNAPTIC INTERACTION. 
 
     
1. The conduction system of the heart  
 
The cardiac muscle (myocardium) is formed by terminally differentiated cells, called 
cardiomyocytes (CM). Working cardiac myocytes are linked one to the other by 
intercellular connection, forming the intercalated disk (ID)[6]. They are classified in three 
complexes: fascia adherens, desmosome and gap junction.  
Desmosome are adhesion junction that connect the cells with the intermediate filaments in 
particular in area that undergoes physical stress, such as cardiomyocytes [7]. Desmosomal 
proteins are: 
(a) Cadherins (desmogleins and desmocollins) that are essential in forming adhesive 
cell-cell interaction[7, 8]. 
(b) Plakoglobin and Plakophilins, that are cytoplasmic cadherins regulating cadherins 
adhesion activity[7, 8]. 
(c) Plakins (desmin), that binds the intermediate filaments[7, 8]. 
Fascia adherens are the linking between the cell membrane to the actin cytoskeleton[7, 8]. 
This complex is formed by:  
(a) Cadherins that regulates cell-cell adhesion[7, 8]. 
(b) Catenin that modulate cadherine adhesive activity [7, 8]. 
(c) Vinculin and α-actin that link the ID to the cytoskeleton [8, 9]. 
Gap junctions are intercellular pores or channel formed by connexin [7, 10]. Six connexin 
complex interacts with another one in the adiacent cells to form hexameric hemichannel, 
called connexon. This complex permits the electrical coupling between the cells allowing 
to small molecule to pass troughout the cytoplasm of the adiacent cells[7].  
Cardiac tissue is divided in two components: working myocardium, formed by cells that 
have contractile function and the conduction system formed by modified cardiomyocytes 
that propagate the electrical pulses that trigger the contraction (pacemaker). 
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The heart contracts spontaneously and rhythmically starting from atria and going to 
ventricles with a precise delay of activation of the two chamber to allow the atria to pump 
the blood into the ventricle[11]. 
Cardiac impulse is generated in the sinusnode and it is conducted through the atrial 
myocardium to the atrioventricular node. Having reached the atrio-ventricular node it is 
delayed to trigger the atrial contraction and to fill the ventricle before reaching the 
atriovenetricular axis and the Purkinje fiber to initiate the ventricle contraction to expel the 
blood from the venetricle chamber[11] (FIG. 1).  
 
 
2. Role of Ca2+ in normal cardiomyocytes 
 
Proteins involved in Ca2+ handling constitute a critical signaling pathway in cardiac cells. 
At the beginning of each heartbeat, an action potentially triggers the opening of voltage-
gated Ca2+ channels located on the plasma membrane or transverse-tubules (T-tubule), 
initiating Ca2+ flow into the cytoplasm of the cardiomyocyte. A small amount of Ca2+ ions 
are sufficient to activate a further release of Ca2+ from the sarcoplasmic reticulum (SR) via 
the ryanodine receptor (RyR2) in a process referred to as calcium-induced calcium release 
[12]. The increase in free [Ca2+] in the cytoplasm activates the interaction between actin 
and myosin filaments responsible for sarcomere shortening (systole). Because a 
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synchronized activation of several acto-myosin cross-bridges is essential to an effective 
force generation, [Ca2+] has to increase within a narrow time frame throughout the whole 
cell [13]. This is accomplished through the subcellular localization of the Ca2+ release sites 
(the RyRs), which are located in close proximity to the Ca2+ entry channels on the 
membrane, and evenly distributed with respect to Ca2+ sensitive sarcomeric proteins [13] 
[14]. For relaxation to occur at the end of the systole [Ca2+] has to rapidly decrease below 
the threshold of activation of acto-myosin bridges. Most of the Ca2+ is pumped back into 
the SR by ATP-dependent pumps (SERCA2a) while a minor amount of Ca2+ is extruded 
from the cell by membrane-bound proteins (Plasma Membrane ATPases, Na+/Ca2+ 
exchanger) [13]. The amount of force generated by the cardiomyocyte depends on the 
speed and amplitude of the [Ca2+] rise and on its spatial distribution throughout the 
cellular matrix. Relaxation, by contrast, depends on how efficiently Ca2+ is removed from 
the cytoplasm. 
The sympathetic nervous system (SNS) provides an important mechanism for regulating 
the force of cardiac contraction in response to the metabolic requirements of the peripheral 
organs during stress including exercise. The release of catecholamines by the SNS 
activates β-adrenoreceptors (β-ARs) that are coupled with G-proteins and adenylyl-
cyclase, which cause elevation of the second messenger cyclic-adenosine-monophosphate 
(cAMP). cAMP activates protein kinase A (PKA), which phosphorylates many of the key 
proteins involved in Ca2+ handling. Phosphorylation of the Ca2+ channel [15] [16] and the 
RyR [17] leads to enhanced sensitivity to voltage and Ca2+-dependent activation, 
respectively. The combined effect of these signaling events is an increase in the amount of 
Ca2+ available for the sarcomere during systole with a consequent increase in myocardial 
contractility. By contrast, PKA-dependent phosphorylation of the SERCA2a-associated 
protein phospholamban [18], which constitutively inhibits the activity of the pump, leads 
to faster Ca2+ removal from the cytoplasm and more efficient myocyte relaxation. 
 
3. Cardiac sympathetic innervation 
 
Sympathetic ganglia chain is the connection between the heart and the central nervous 
system [19].  
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Cardiac sympathetic neurons modulate cardiac activity by increasing the force and the 
frequency of heart contraction, mediating the response known as ‘flight or fight response’. 
Preganglionic sympathetic neurons are located in the central portion of the lumbar spinal 
cord, and project to the sympathetic ganglia chain, which runs bilaterally to the spinal cord.  
The superior of the sympathetic ganglia chain is the cervical ganglia, and together with the 
stellate ganglia it contains the bodies of the majority of the cardiac postganglionic neurons. 
Postaganglionic sympathetic nerves join the cardiac plexus, formed by the vagus fibers 
and the sympathetic neurons (SN), and run along aortic arch and reach coronary vessel to 
originate the coronary plexus, giving rise to the collateral branches that innervate the heart. 
SN innervations exhibit heterogeneous distribution inside the myocardium: the 
subepicardial regions displays higher SN density than the subendocardial region[20]. 
Sympathetic nerve fibers develop, with a mechanism regulated by NGF [21, 22],  from the 
base of the the heart into the myocardium, and are located mainly in the subepicardium 
[20].  
The signals are transferred from SNS to the heart through the release of catecholamines, 
mainly norepinephrine (NE), that interacts with the β adrenergic receptor (β-ARs) 
localized on the cardiomyocyte membrane. In particular during stress or exercise the 
activity of the sympathetic nervous system leads to a increase in the cardiovascular 
function through the β-ARs activation inducing an increase in the intracellular cyclic-
AMP (cAMP), which in turn activates PKA, mediating phosphorylation of proteins 
involved in Ca2+ homeostasis, increasing the availability of Ca2+, essential for sarcomere 
contraction, leading to an inotropic and positive chronotropic effect. 
 
4. Βeta adrenergic receptor mediated pathway 
 
NE is released by SNS and modulates cardiac activity inducing both inotropic and positive 
chronotropic effects during exercise or stress. The control of cardiac activity occurs via 
activation of the β-ARs, that are G protein-coupled receptor (GPCR) localized on the 
membrane of the CM. NE interacts with β-ARs leading to the activation of adenylyl 
cyclase (AC) [23], which is the cAMP synthesizing enzyme. Cyclic-AMP activates its 
effectors, and in particular the cAMP-dependent protein kinase A (PKA), that 
phosphorylates several cytoplasm and nuclear targets. The increase in force and frequency 
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of heart contractions is controlled by the phosphorylation of the L-type Ca2+ channel [24] 
and the RyR2, increasing the intracellular Ca2+ content that are essential for sarcomere 
contraction during systole [25]. PKA activity is essential in the control of  Ca2+ reuptake in 
the sarcoplasmic reticulum during diastole, by the phosphorylation of phospholamban 
(PLB) mediating the activation of SERCA proteins, that results in increased efficiency of 
cytosolic Ca2+reuptake by the sarcoplasmic reticulum [26] (FIG. 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Given the fact that NE spillover, due to SNS overactivation, occurs in patients affected by 
heart failure and arrhythmic events [27] and that administration of  β-AR blockers is the 
main therapeutic strategy against arrhythmias, it becomes important to investigate whether 
SNS controls specifically the target cardiac cells and how the sympathetic nerve fibers 
exerts they control in the target CMs.  
 
4.   Βeta adrenergic receptor subtype role in cardiomyocytes intracellular 
signaling 
 
CMs express two major β-AR subtypes: β1 and β2 –ARs. Both are members of the G-
protein coupled receptor (GPCR) and control the force of CM contraction through 
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phosphorylation of plasmalemmal and sarcomeric ion channels and contractile proteins, 
by increasing intracellular cAMP [28]. Stimulation of β-ARs leads to production of cAMP 
that activates PKA inducing phosphorylation of proteins essential in muscle contractility, 
mediating the catecholamine effect on cardiac performance. Although β1-ARs and  β2-ARs 
are activated by the same agonist, the selective stimulation of one subtype leads to 
different responses in heart contractility. Indeed, alternative stimulation of the receptor 
elicits different physiological responses [29], and it has been suggested that activation of 
β1 -AR-mediated pathway could have a role in the pathogenesis of heart failure [30, 31]. 
β1-AR stimulation influences the heart contraction rate more than β2-ARs [29, 32] with a 
PKA dependent mechanism [33]. Indeed Devic et al. examined CM contraction rate in 
presence of a PKA inhibitor in CM isolated both from β2-AR KO mice and from β1-AR 
KO mice. They observed a small increase in CM  activity in the β2-AR KO CMs 
compared to the β1-AR KO ones, suggesting that the β1-AR pathway is PKA dependent 
[33].  
The two receptor subtypes have also different distribution in the cell surface: by using 
scanning ion conductance microscopy (SICM) with measurements of cAMP production 
by using FRET-based approach, it  has been shown that selective activation of β1-AR in 
isolated adult CM was achieved by stimulating the cell crest areas, on the contrary 
activation of β2-ARs was obtained stimulating the T-tubular region [34]. Moreover the 
response mediated by the β-ARs triggers different compartmentalization of the 
intracellular cAMP. FRET-based measurements in adult CM show that β1-AR selective 
activation induces intracellular cAMP increase that diffuses through the entire cytoplasm, 
instead β2-AR-mediated signal remain restricted to local domains.  
The control of the selective β-AR mediated cAMP increase is modulated by different 
PDEs, β1-ARs cAMP signal is controlled especially by PDE4, on the contrary β2-AR 
pathway is controlled by multiple PDE isoforms [35]. 
It has been demonstrated that in patients affected by heart failure occurs an increase in the 
plasma concentration of NE due to the over activation of sympathetic nervous system [36], 
and this could lead to a desensitization in the β-ARs, in particular it has been shown that in 
pacing-induced heart failure in dogs occurs a downregulation of β1-ARs before the 
developing of the heart failure [37]. In line with these data, there is evidence of a reduction 
of mRNA level of β1-ARs in failing heart biopsy, and this decrease is correlated with the 
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severity of the disease [38]. Considering that it has been demonstrated that β1-AR are 
enriched in the region of the heart that interact with a sympathetic neurons [3], β1-AR 
downregulation could be involved in a disruption of a SN-CM specialized interacting site 
that modulates heart rate during stress or exercise.  
Taking into account this consideration it becomes important to understand whether 
autonomic regulation of cardiac performance through β-ARs occur by specialized 
interaction between SNs and CM or by a non-structured connection, in order to investigate 
the pathophysiological role of SNS in arrhythmia triggering. 
 
5. FRET Measurements of cAMP and PKA activity in living cells  
 
To monitor cAMP variation and PKA activity in the cytoplasm of living cells become 
important in order to assess CM intracellular signaling upon β-AR stimulation with high 
temporal resolution. In the last few years FRET-based biosensors were developed. In this 
work we used two different FRET-based probes: EPAC1-camps and AKAR3, to monitor 
cAMP increase [39] and PKA activity, respectively [40]. FRET (Förster resonance energy 
transfer) is an event that describes a transfer of energy between two chromospheres. A 
donor chromophore which is in the excited state may give a part of the energy to excite the 
acceptor chromophore. The efficiency of the transfer depends on chromophores 
orientation, on the acceptor-donor distance and on fluorophore spectra that have to be 
overlapped. This property of the fluorescence protein was applied to build up genetic 
encoding probes to monitor intracellular messengers variation in living cells.  
EPAC1 is a protein which is activated by cAMP [41] produced by β-AR stimulation. 
EPAC1 was fused with two fluorescence protein suitable to making FRET (CFP, donor 
and YFP, acceptor) [39] and it is expressed in cells by transient transfection. When the 
intracellular concentration of cAMP is low, EPAC1 is not activated and the two 
chromophores are one close to the other inducing high FRET signal. When intracellular 
cAMP increase, EPAC1 is activated and undergoes conformational changes, augmenting 
the distance between the two chromophores, with a decrease in the FRET signal [39] (FIG 
3). cAMP variation is measured as ratio between the fluorescence intensity of CFP and the 
fluorescence intensity of YFP. 
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AKAR3 biosensor detects PKA activation by cAMP. AKAR is a four part chimeric 
protein made of CFP, a phospho-amino acid binding domains, a PKA specific 
phosphorylatable sequence, and YFP [40]. When PKA is deactivated the distance between 
CFP and YFP is high and there is no transfer of energy between the two fluorophore; 
cAMP-activated PKA phosphorylates the target sequence of the biosensor changing its 
conformation interacting with the phospho-amino acid binding domains; in this way the 
distance between CFP and YFP decreases and the energy trasfer can occurs [40] . PKA 
activity is assessed as ratio between the fluorescence intensity of YFP and the 
fluorescence intensity of  CFP [40]. 
AKAR biosensor was improved by changing the fluorescence protein: a pair of yellow and 
cyan fluorescence protein, CyPet and Ypet was fused. Indeed CyPet and Ypet  are optimal 
FRET pair, that gives higher FRET efficiency than other chromophores couples[42]. This 
improved FRET-based biosensor is AKAR3 (FIG 4). 
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With these biosensors we were able to monitor both cAMP variation and PKA activity in 
living cells to investigate β-AR intracellular signaling triggered by sympathetic neurons 
(SN).  
Plasmid encoding for EPAC1 or AKAR3 were expressed in plated-cells by transient 
transfection. Cells were rinsed and maintained in a Ringer-modified saline (for FRET 
recording. Cells were imaged on an inverse fluorescent microscope (IX50, Olympus) 
coupled to a CCD camera (Sensicam QE, PCO) and a beam-splitter optical device 
(Microimager) (FIG. 5A).  
Coverslips with cells attached were put onto the objective. FRET intracellular variations 
were recorded during time with high temporal resolution. Cells expressing FRET-based 
probe were excited at 436 nm (CFP). The emitting light ( CFP and YFP signal ) was split 
in two channel by a beam splitter device, and two image (CFP and YFP) are detected by a 
CCD camera and transferred to a dedicated computer using custom-developed software 
(Roboscop) (FIG. 5B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
After PKA activation the ratio YFP/CFP displayed increases, on the contrary after EPAC1 
activation the ratio YFP/CFP displayed decreases. FRET values were expressed as ∆R/R0, 
where R0 is the ratio at t = 0 s and ∆R = R - R0. 
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6. In vitro and in vivo evidence of specialized interaction between SN and CM 
 
The heart is densely innervated by sympathetic neurons that regulate cardiac function 
during exercise and stress through β-ARs activation. To date, whether the sympathetic 
neurons interacts with the cardiomyocytes with a direct cell-cell interaction or if the 
autonomic control of the heart is mediated by diffuse release of catecholamines in the 
tissue not specific, is still elusive. 
A suitable in vitro model to study sympathetic neruons-cardiomyocytes interaction is 
represented by SN-CM co-cultures. There are studies in which a close interaction between 
SN and CM has been suggested. Electron microscopy analysis (EM) on SN-CM co-
cultures showed presence of varicosities containing synaptic vesicles along the axons at 
20-30 nm from the myocyte surface [43], and there is evidence that electrical stimulation 
of SN induces an increase in the contraction rate in co-cultured CMs[3, 44-46] due to NE 
release from catecholamine-releasing terminal interacting with the ventricular myocytes 
[46]. Marvin et al. in 1984 performed co-cultures between sympathetic chain explants 
with isolated ventricular myocytes, observing that axons migrated from the sympathetic 
chain tissue interacts with ventricular cells avoiding the connection with the non muscle 
cells. To verify the functional connection between those neurons and the cardiac cells they 
monitored the CM beating rate upon nerve stimulation, showing increase in the 
contraction frequency in co-cultured CM [47].  
This evidence is supported by the fact that electrical stimulation of SN induces variation in 
the electrical properties of the coupled-cardiac cells in vitro [48], and that NGF treatment 
elevates spontaneous beating rate of the coupled-cardiac cells [22], implying that the 
innervation is functional and cardiac specific.  
In accord with this hypothesis, it has been demonstrated that sympathetic innervation 
influences protein expression and localization of the co-cultured CMs. Indeed SN 
innervation lead to an increase in the L-type Ca2+ channel expression [46], that is essential 
in the myocyte contraction during the CICR event, and β1-ARs were enriched in 
specialized zone that surround contacting axon, in close proximity of scaffold protein such 
as AKAPs and SAP97 [3]. All these data support the hypothesis of existence of a 
specialized site that modulates cardiac activity by releasing NE that interacts with the 
post-synaptic β-ARs. 
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A model in which autonomic control of contractility occurs through direct interaction 
between the neurons and their target CM could be also suggested by the fact that 
impairment in the SNS function could lead to arrhythmias [49], supporting the idea of the 
existence of specific interaction between SNS and heart. First of all, it has been 
demonstrated that unbalanced sympathetic input of cardiac innervation is involved in the 
arrhythmic events [50]. Indeed it has been observed that the autonomic innervations in dog 
affected by inherited arrhythmias have a heterogeneous distribution: there were area of 
denervation in the apical, anterior, septal, and lateral regions of the left ventricle [50].  The 
connection between unbalanced sympathetic innervations and the arrhythmias triggering is 
also supported by the fact that patients affected by ventricular arrhythmias have a 
sustained activation of the sympathetic nervous system [49] and after myocardial 
infarction (MI) sympathetic innervation increased in the peri-injured area [27, 51] with 
upregulation of several growth factor such as Nerve Growth Factor (NGF) [51] and 
disappeared in the necrotic area [27, 51]. Thus, MI-induced nerve growing created 
heterogeneous distribution of the sympathetic innervation, with hyperinnervated, 
denervated areas and normal nerve fiber density [51].  
Therefore considering that MI leads to VT-related hyperinnervation and heterogeneous 
sympathetic nerve distribution that is involved in arrhythmia triggering, it has been 
suggested that SNS impairment is involved in the genesis of arrhythmic event in diseased 
hearts.  
Moreover it has been demonstrated that, in isolated and perfused heart with chronic MI 
and failure, it has been shown that the proarrhythmic input is sympathetic nerve 
stimulation, that triggers a β-AR-mediated arrhythmic event [52], that could be originated 
by hyperactivation of SNS also in patients without conventional risk of sudden cardiac 
death [53].  
Sympathetic nerve stimulation in failing myocardium leads to the release of NE through 
nerve endings, thus hyperactivation of SNS could increase the release of NE. These events 
support the evidence that NE spillover in the plasma occurs in patients with heart failure 
[36, 37], due to impairment in the SNS function caused by unbalanced hyperactivation of 
sympathetic nerve or failing in the NE reuptake by norepinephrine transporter (NET). 
Indeed it has been proposed a significant reduction of NE-analog (MIBG) uptake in 
patient with idiopathic ventricular fibrillation [54], and NET-/- mice show increase in the 
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plasma NE with increase in the heart rate [55], as occurs in patients with failing 
myocardium condition, suggesting a possible trigger mechanism for arrhythmic events. In 
addition, Myles et al. recently provided evidence that NE stimulation of small fraction of 
cardiac cells is sufficient to trigger a premature ventricle complex in isolated and perfused 
heart[56], raising the hypothesis that β-local adrenergic activation is involved in triggering 
arrhythmic event in pathophysiological states, and such dysfunction leads to the activation 
of a limited fraction of cardiac cells sufficient to generate premature beat in the whole 
heart. 
These data support a model in which autonomic control of small fraction of cardiac 
function relies on specialized interaction sites of direct interaction between the neurons 
and their target CM.   
The autonomic stimulation of the heart during exercise or stress condition is a trigger 
mechanism also in stress-related inherited arrhythmias, such Cathecolaminergic 
Polymorphic Ventricular Tachicardia (CPVT). Thus, become important to understand 
whether the sympathetic nerve fiber control a limited group of cells, in order to understand 
which the fraction of CPVT-cardiac is cells that have to be depolarized o trigger the 
arrhythmic event. 
 
7. Cathecolaminergic Polimorphic Ventricular Tachicardia (CPVT) 
CPVT is inherited arrhythmia that leads to syncope and sudden death during stress or 
exercise. Electrocardiography analysis on patients without any conventional risk of sudden 
death, affected by CPVT is characterized by stress-related ventricular tachycardia (VT), 
leading to fibrillation or cardiac arrest. To date the only therapeutic strategy is the use of 
β-blockers, but 30% of the treated-patients develop strong VT [57].  
There are two genetic variants of CPVT: autosomal dominant form, caused by the 
mutation of the gene coding for Ryanodine receptor2 (RyR2) [58], and autosomal 
recessive form, caused by the mutation of the cardiac isoform of Calsequestrine2 
(CASQ2) [59] . The autosomal-dominat form of CPVT is characterized by missense 
mutations in RyR2. However the molecular mechanism involved in the arrhythmias 
triggering is debating  (FIG. 6). 
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During exercise or stress condition heart increase the beating rate by the release of NE 
from SNS that interacts with β-AR activating PKA through cAMP pathway. PKA 
activation induces phosphorylation of several proteins , in particular RyR2 [25]. RyR2 is a 
Ca2+ permeable channel localized in the membrane of sarcomplasmic reticulum (SR), that 
upon phosphorylation shift in a open conformation allowing the passage of  Ca2+ from SR 
lumen to cytosol increasing intracellular Ca2+ availability to cardiac contraction [60]. 
PKA phosphorylation triggers displacement of a protein, Calstabin2 (FKBP12.6), that 
keep the channel in the close state, increasing the open probability (Po) of the channel 
[61]. In vivo and in vitro studies have been shown that RyR2-linked CPVT decreases the 
affinity to Calstabin2 in PKA-mediated phosphoryaltion state [62, 63]. As consequence 
RyR2-CPVT Po is higher than in wt RyR2 in presence of low concentration of cytosolic 
Ca2+ (during dyastole) [62]. Thus a leakage of Ca2+ from SR occurs in CM also during 
diastole leading to activation of the NE+/Ca2+ exchanger  (NCX), that reduce the 
membrane potential to the threshold potential to activate NE+ channel, triggering a 
premature beat during diastole[64]. Thus the leakage of Ca2+ from mutated-RyR2 causes 
membrane potential instability that could lead to arrhythmic events. 
In other study RyR2 mutation linked to CPVT increase the store overload-induced Ca2+ 
release (SOICR)[65], an event in which the increase in the SR luminal Ca2+ induce 
spontaneous leakage of Ca2+ by RyR2. In support to FKBP12.6-indipendent mechanism 
there are in vitro studies showing that the dissociation between FKBP13.6 and RyR2 does 
not cause the CPVT-phenotype[66] 
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These different interpretations of triggered arrhythmias in CPVT, could also change the 
strategy on developing molecular approaches to correct functional defect, thus it becomes 
important understand the pathophysology of CPVT that is not completely clear.  
Patients affected by CPVT at ECG analysis has normal heart structure and normal QT 
interval [67]. During the arrhythmic event they show ventricular extrasystole following by 
bidirectional ventricular tachycardia that could degenerate into ventricular fibrillation[67]. 
It implies that the arrhythmic events originate from an irregular activity of a limited group 
of cells, thus it becomes important whether the increase in the P0 of RyR2 of a small group 
of cardiomyocytes is sufficient to trigger VT events. 
In a part of this project we set up a channelrhodopsin2-based mouse model to investigate 
which is the fraction of cells that have to be depolarized to trigger an arrhythmic event 
both in normal condition and in CPVT condition, and understand the role of SNS in the 
VT triggering. 
 
8. Channelrhodopsin2 (ChR2)-based approaches to modulate exitable cells 
activity 
ChR-microbial proteins are light-gated cation channels localized in the plasma-membrane 
of the cells. They are rhodopsin-like proteins with a seven transmembrane domain that 
undergoes conformational changes upon absorption of photon[68], allowing the passage of 
the ion within the channel (FIG.7).   
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The wavelength to trigger the activation, the ion selectivity and conductance differ among 
the ChR-variants [68]. In this work we used ChR2 which is a variant of the ChR protein 
that is part of phototactic apparatus of algae Chlamydomonas reinhardtii[69]. ChR2 
activation upon blue light (470 nm) triggers a conformational change that allows the 
passage of Na+ with millisecond resolution [4, 68].  
ChR2 has successfully been used to modulate neuronal circuits with light pulses[4, 5, 70, 
71] or to control neurons activity in brain slices[72]. Indeed it has been demonstrated that 
ChR2-positive neurons in cortical slices triggers rapid current sufficient to elicit an action 
potential[72]. This ChR2 property has also been shown in the entire brain, in fact 
Deissand co-workers induced expression of ChR2 in the motoneurons and using a 200µm 
fiber optic they were able to modulate mouse behavioral in a non-invasive and time- 
controlled way[72] and to map neural circuits in the brain [73].0 
Thus ChR2 stimulation with blue light induces a depolarization sufficient to trigger an 
action potential in neuronal cells and it is useful to fast-modulate brain activity and 
behavior of living animals.  
ChR2-based approach is suitable to modulate the activity of other excitable cells. Indeed 
this novel approach is applied also to control cardiac cells activity, modulating by light 
both electrical properties of cardiac cells obtained by stable transgenic mouse embryonic 
stem cell line expressing ChR2(H134R) and electrophysiological behavior of the heart[74].  
ChR2 become a useful tool to control cardiac activity in vitro and in vivo, allowing to 
stimulate a limited number of cells in the heart. Thus this strategy let us depolarize the 
heart in different region of decreasing size to understand the fraction of cells that have to 
be depolarized to trigger an arrhythmic event. 
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Aims of the project 
 
The data here presented suggest that SN innervation of the heart determine a specific and 
regulated domain with the target cells. Indeed EM analysis on SN-CM co-cultures showed 
that SN interacts closely with the CM forming organized structure where ST interacts with 
the cardiac cells[43].  Moreover it has been shown that SNS overactivation is involved in 
the trigger mechanism of heart failure and arrhythmic event in physiological and 
pathophysiological condition, such as MI [49, 51]. Impairment in the sympathetic nerve 
electrophysiological properties lead also to NE spillover in patients with history of 
tachiarrhythmias or heart failure[36], due also to an impairment in the NET function[54]. 
Increase in the NE concentration is suggested to be one of the trigger mechanism of 
arrhythmic events, and local administration of NE is sufficient to trigger a premature beat 
[56].  
All the evidence here provided supports a model in which the autonomic control of the 
heart occurs in a specialized synaptic site in which NE is released controlling CM 
intracellular signaling. Taking into account all this consideration we made the hypothesis 
that impairment of autonomic innervations could caused a variation of electrical properties 
of a limited group of cells sufficient to trigger a premature ventricle beat. 
Thus the aims of this project are: 
 
1. To investigate whether specific cell-cell interactions have a role in the dynamics of 
intercellular signaling between SN and CM. 
2. To understand whether the unbalanced SN modulation of a limited group of 
cardiac cells could be involved in generating arrhythmias in vivo using a ChR-
based strategy. 
3. To study in vivo, non-invasively, the critical mass of myocardium necessary to 
generate an arrhythmogenic focus based on a ChR2 approach. 
 
In Chapter 1 I will provide evidence of the existence of a SN-CM specialized and 
restricted releasing site, using an in vitro model. To provide also this evidence in vivo in 
chapter 2 I will describe a bioinformatic model of ChR2 that allow to understand the 
32 
 
structure of the protein, adding preliminary results that show how ChR2 based strategy 
allow to control the neuronal-like cells behaviour in vitro and also SN activity in vivo. 
Finally in chapter 3 I will show a novel system to optically control heart activity in normal 
condition or during pro-arrhythmic condition, showing the critical mass necessary to 
trigger a premature ventricle beat. This work is currently ongoing, and we are performing 
additional experiments to increase the trial number. The results of the present discussion 
constitute one manuscript currently in submission, one in preparation and one published. 
Each of these pieces of work will appear in separate chapters. 
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Live imaging of the neurocardiac signaling interaction 
 
Abstract 
The heart is densely innervated by sympathetic neurons that regulate cardiac function 
during exercise and stress through β-ARs activation. Unbalanced sympathetic discharge to 
different regions of the heart has been associated with arrhythmia triggering [1], and 
alterations in presynaptic NE reuptake lead to catecholamine spillover in the failing 
myocardium [2]. These data support a model in which autonomic control of contractility 
occurs through direct interaction between the neurons and their target cardiomyocytes 
(CM).  
The aim of this study is to investigate whether specific cell-cell interactions have a role in 
the dynamics of intercellular signaling between autonomic neurons and CMs in vitro. 
Intracellular β-AR-dependent signaling was assessed in intact neonatal rat CM co-cultured 
with superior cervical ganglia neurons (SN) by performing real-time cAMP and PKA 
activity imaging upon SN stimulation with KCl or bradykinin.  
In co-cultures SNs extend their axons upon NGF treatment and establish direct contact 
with CM. Activation of a specific SN lead to cAMP increase in the interacting CM while 
no changes in cAMP were detectable in neighbouring but not directly interacting CMs. 
To assess the [NE] that interact with the post-synaptic β-ARs we set up a pharmacological 
assay using the non-selective β-blocker propranolol. We observed that 10e-5 M of 
propranolol totally inhibits the cAMP increase induced by neurotransmitter released from 
SN. The same concentration of propranolol inhibits the response elicited by 10e-7 M of 
NE administered to CM plated alone, suggesting that the [NE] acting in the synaptic cleft 
is in the order of 100 nM. 
Here we provide evidence of a ‘synaptic’ contact between SNs and CMs that form a high 
agonist concentration, diffusion-restricted space allowing potent activation of a small 
fraction of β-AR on the CM membrane upon neuronal stimulation. 
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Introduction 
 
Cardiac sympathetic neurons modulate heart activity by increasing the force and the 
frequency of heart contraction, mediating the response known as ‘fight or flight response’. 
This suggests that a function coupling exists between these cells. 
Indeed, efforts have been performed since the late 70s to study such cell-cell interaction in 
vitro. Electron microscopy analysis (EM) on neonatal cardiomyocyte and sympathetic 
neuron co-cultures showed the presence of varicosities containing synaptic vesicles along 
neuronal axons 20-30 nm from the myocyte surface [3]. Electrical and pharmacological 
stimulation of SNs modifies the electrical properties of the coupled-cardiac cells in vitro 
[4] and an increase in the contraction rate in co-cultured CMs [5-8], as well as electrical 
stimulation of the sympathetic ganglia explants induces a positive chronotropic response 
in co-cultured ventricular myocytes [9]. 
Dysfunction of the sympathetic nervous system is implicated in several cardiovascular 
diseases, including arrhythmias and heart failure. Heterogeneous distribution of cardiac 
innervations is involved in the arrhythmic events [10]. Patients affected by ventricular 
arrhythmias have sustained activation of  the sympathetic nervous system [11], leading to 
increase in the released NE. Indeed there is evidence that NE spillover in the plasma 
occurs in patients with heart failure [12, 13]. 
Ripplinger and coworkers recently provided evidence that NE stimulation of a small 
fraction of cardiac cells is sufficient to trigger a premature ventricle beat in the isolated 
and perfused heart [14], raising the hypothesis that SNS impairment is involved in the 
triggering of arrhythmic event, and such dysfunction leads to the activation of  a limited 
fraction of cardiac cells sufficient to generate a premature beat in the whole heart. 
All this evidence supports a model in which the autonomic control of the heart occurs in a 
specialized site in which NE is released controlling CM intracellular signaling. 
The existence of specialized sites has been demonstrated for the neuromuscular junction 
(NMJ), where high concentration of neurotransmitter binds to postsynaptic membrane 
receptors accumulated in the synaptic site together with channels, anchoring and signaling 
proteins required for muscle contraction [2]. 
 
36 
 
SNs exert their function by releasing norepinephrine (NE) from nerve endings, leading to 
activation of cardiomyocyte beta-adrenergic receptors (β-ARs). This activates adenylil 
cyclase producing the second messenger cyclic AMP (cAMP) and leading to activation of 
PKA in the cAMP/PKA pathway. PKA mediates its functional effect by phosphorylating 
several cytoplasmic and nuclear targets involved in the increase in force and frequency of 
heart contraction. Thanks to many FRET-based biosensors developed in the recent years, 
it has been possible to monitor cAMP variations in real time in living cells, highly 
improving the knowledge of intracellular cAMP dynamics in cardiomyocytes. 
Given the growing evidence that localization of signaling events in the CM plays a role in 
cardiac physiology and pathology, uncovering the mechanism of neurocardiac regulation 
is of paramount importance.  
We sought here to develop an in vitro model to mimic the interaction between sympathetic 
neurons and cardiomyocytes allowing the study of the physiological β-AR activation in 
CM cAMP/PKA signaling. We set up co-cultures between neonatal rat CM and superior 
cervical ganglia neurons. We performed real-time cAMP and PKA activity imaging with 
the FRET-based biosensor EPAC1-camps and AKAR3, respectively, in CM coupled with 
SN. 
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Results 
 
Co-cultures between cardiomyocytes and sympathetic neurons as an in vitro model to 
study cell-cell interaction and intercellular signaling. 
 
The sympathetic nervous system represents the fundamental modulator of cardiac activity, 
regulating heart rate, conduction velocity and myocardial contractility through the release 
of catecholamine and activation of β-adrenergic receptors (β-ARs). The evidence 
describing the role of β-ARs in regulating the intracellular signals controlling myocardial 
function has been so far accrued on isolated cellular preparations, in most cases with 
exogenous pharmacological receptor stimulation. Sympathetic neurons activation, 
however, is the main mechanism whereby the β-ARs are stimulated in the living 
organisms. Although the distribution of cardiac sympathetic neurons (SNs) is well 
established, and so is the mechanism leading to catecholamine release, it is currently 
unclear whether a specific cell-cell interaction between SNs and their myocardial targets 
exists.  
We have established an in vitro model to mimic the physiological interaction between SNs 
and cardiomyocytes (CMs) by setting up co-cultures of neonatal rat neurons isolated from 
the superior cervical ganglia and ventricular CMs. 
Myocytes and SNs were cultured on the same coverslip and kept in 2nd day medium 
supplemented with 100 ng/ml of NGF. After 1 week in culture, SNs have developed axons 
that take contact with several CMs [15, 16] (Figure 1A, and B). This situation mirrors the 
condition in vivo, where a dense pattern of cardiac sympathetic innervation is present, as 
shown for ventricular cryosections of adult mouse hearts stained with an antibody to 
synapsina 1a (, FIG. 1D). Immunofluorescence analysis reveals that a close interaction of 
single actively-releasing neurons with different cells exist, as presented in ventricular 
cryosections from adult mouse hearts where the CM membrane is stained with FITC-
conjugated wheat germ agglutinin and neurotransmitter-releasing sites are depicted with 
an antibody specific for synapsina 1a (Figure 1 C). 
In co-cultures, accumulation of synapsinI in the pre-synaptic membrane (Figure 1C) and 
β-catenin and cadherins in the CM membrane was observed at the site of contact [6] (and 
data not shown). 
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These results indicate that in our co-cultures specialized connections form between the 
two cell types and that our system is feasible for studying the intercellular signaling 
between SNs and CMs. 
 
Intracellular cAMP dynamics in cardiomyocytes coupled to sympathetic neurons 
upon neuronal activation. 
 
To investigate whether the CM-SN synaptic contact is functional, we set out to measure 
intracellular cAMP levels in CMs coupled to SNs by expression of the cAMP FRET-based 
biosensor Epac1-camps in CMs prior to co-culture establishment (FIG. 2A). This sensor 
reports on cAMP levels by monitoring FRET between CFP and YFP fused to the cAMP 
binding domain of an isoform of the exchange protein directly activated by cAMP[17] 
(Epac1). Accumulation and subsequent binding of cellular cAMP induces a 
conformational change that decreases the FRET efficiency between the two fluorescent 
proteins. Therefore, the ratio between CFP and YFP emission is proportional to the 
concentration of intracellular cAMP ([cAMP]
 i). 
SNs were stimulated by applying high potassium solution (50 mM) to the cell bath, 
followed by washout with saline solution (5 mM K+). This treatment causes the onset of a 
train of action potentials and direct membrane depolarization that stabilizes to a membrane 
potential of about 0 mV that lasts as long as high KCl is present (Fig. 2B), and subsequent 
rapid intracellular calcium increase (FIG. 2C) by influx through voltage-gated calcium 
channel. This event is necessary for the exocytotic release of norepinephrine (NE). 
Under this condition, SN depolarization induced an increase in [cAMP]i in innervated 
CMs. In FIG. 2D, a representative trace of CM [cAMP]i monitored as increase in the ratio 
between the 480 nm/535 nm emission signals (R) over the value at t = 0 s (R0) is 
illustrated. The graph also shows the increase in [cAMP]
 i upon 1 nM and 10 nM NE 
administration to the cell bath in the same cell, used to monitor for single cell health and 
responsiveness. In CMs contacted by SNs, the increase in [cAMP]i upon 50 mM KCl 
stimulation was higher (∆R/R0 = 5.61 % ± 0.01 mean ± SEM, n = 8) in comparison to 
myocytes in co-culture but without synaptic contacts and myocytes cultured alone (∆R/R0 
= 1.70 % ± 0.01 mean ± SEM, n = 12) (FIG 2E, 2F). The fact that in CMs in co-culture 
but without sympathetic contacts [cAMP]i  increase was not observed indicates that this 
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effect is specific and not simply due to NE released into the medium by simultaneous 
depolarization of all SNs in culture. Synapse formation was confirmed by incubating the 
cells with FM1-43 (not shown).  
To further exclude the possibility that the increase in CM [cAMP]i could be caused by 
unspecific release of NE in the medium by depolarized SNs, we puffed high potassium 
solution specifically to the SN coupled to the CM under observation. This was achieved 
via positioning the tip of a picospritzer pipette in proximity to the SN and applying a 
pressure of 5-10 psi for up to 10 s.  
To verify that the puff is sufficient to induce depolarization SNs were loaded with Fluo4-
AM and intracellular calcium increase with was monitored. 
A brief puff of KCl (5 psi, 10 s) delivered to the soma induced a rapid increase in 
intracellular calcium in SNs (t1/2 = 1.23 s ± 0.33, mean ± SEM, n=4) (FIG. 3A). 
Using the same protocol e measured intracellular cAMP variation in innervated CM. we 
observed that brief KCl puff induces increase in [cAMP]i (∆R/R0 of 1.724 % ± 0.003, 
mean ± SEM, n = 3) was detected (a representative trace is shown in FIG. 3B).  
 
The comparison of calcium dynamics in SNs and cAMP increase in CMs shows that 
cAMP production starts about 2 s after the increase in intracellular calcium and is at about 
half of its peak when calcium concentration is at its maximum  
In about 15% of the CMs analyzed, high potassium administration induced a transient 
increase in [cAMP]i with ∆R/R0 of 6.59 % ± 0.008 (mean ± SEM, n= 2).  
Our results indicate that a functional synaptic contact form between SNs and CMs in co-
culture, whereby single SN activation can specifically control the intracellular signaling of 
coupled CMs, possibly via β1-ARs. 
This evidence is also supported by the fact that structural organization occurs in the CM 
membrane under ST, in particular that  β1-ARs are enriched in the region of SN-CM 
contact [6]. Using β-ARs subtype tagged with a HA (β1-ARs) or flag (β2-ARs) we verified 
receptor localization in our model. FIG. 4A represent a confocal image of SN interacting 
with CM expressing β1-HA. In contacting region (indicated with the arrows) we observed 
accumulation of the receptor, on the contrary in non-interacting region the expression of 
the receptor is lower. Instead β2-ARs are evenly distributed on the plasmamembrane of 
CM, also in the interacting region (FIG. 4B).  
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These differences in the localization allow us to think that neurocardiac coupling is mostly 
β1-AR mediated. Thus we performed the functional assay previous described in presence 
of selective β-ARs blockers. We observed that the SN-induced cAMP response in 
presence of β1-AR blocker (CGP 12177A, 50 nM) is lower to that induced in presence of 
β2-AR blocker (ICI 118511, 40 nM), confirming the fact that SN control XM activity 
mainly via β1-ARs (FIG 4C). In conclusion these results indicate that the specific 
neurocardiac regulation occurs possibly via β1-AR. 
 
Quantification of the SN-released NE in the synaptic cleft 
 
It has been demonstrated that SN influence CM contraction rate [6, 7], and here we have 
provided evidence that such interaction is specific and determines a domains in which NE 
is released activating mostly β1-ARs.  
To understand which is the NE concentration acting in the synaptic cleft we compare the 
variation of the FRET ratio of EPAC1-camps raised from administration of different 
concentration of NE given to the bathing solution to that elicited by SN-released NE 
( ∆R/R0= 2.6 % ± 0.6%, mean  ± SEM, n=13).   
We measured the effect of NE as percent of maximal response (fig. 5A). The variation in 
the CFP/YFP ratio induced by SN-released NE (2.6%) is comparable to that induced by 
3.5e-10 M of NE administered to the whole cells (FIG. 5A dotted line, 5B).  
However, sympathetic-releasing terminal interacts with a limited fraction of the membrane 
of the coupled-CM, so the cAMP increase achieved by SN-released NE is due to a 
stimulation of a small number of high-density receptor. On the contrary cAMP variation 
elicited by exogenous administration of NE is triggered by stimulation of β-AR distributed 
on the plasmamembrane, implying that the β-AR activation induced by SN-released NE is 
triggered by high concentration of neurotransmitter that activate a limited but high 
receptor density fraction of the membrane of the coupled CM. 
To assess the [NE] that interact with the post-synaptic β-ARs we set up a pharmacological 
assay using the non-selective β-blocker propranolol. Propranolol is a competitive 
antagonist of NE, meaning that at increasing concentration, propranolol competes with 
SN-released NE in the β-AR receptor site until the response is abolished. We standardized 
the amount of NE released from SN by stimulating the sympathetic nerve for a fixed 
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period of time (15 s). In this way we have a model in which the unknown amount of NE 
discharged is stable and the concentration of antagonist is changed in order to understand 
which is the amount of β-blocker needed to completely abolish the response triggered by 
SN-released NE. We observed that low concentrations of propranolol (100 nM, 200 nM9 
do not inhibit the response induced by SN, but are sufficient to abolished the response 
triggered by 3.5e-10 M of NE (FIG 5B) confirming the hypothesis that NE acts in a 
limited fraction of the membrane activating high-density receptor. 
We build up a dose response curve of NE in presence of propranolol and we observed that 
10e-5 M of propranolol totally inhibits the cAMP increase induced by neurotransmitter 
released from sympathetic nerve endings (FIG. 5C).  
We performed the same experiment by administering a known concentration of NE to CM 
plated alone in presence of increasing concentration of propranolol.  
We found out that the response elicited by 10e-7 M of NE given to all the receptor is 
totally abolished by 10e-5 M of propranolol (FIG 5D). 
These data show that the response achieved by NE released from sympathetic neuron 
endings is abolished with the administration of 10e-5 M of propranolol which is the 
concentration needed to inhibit the cAMP increase triggered by 10e-7 M of NE. This 
implies that the concentration acting in the synaptic cleft is in the order of 100 nM. 
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Material and Methods 
 
Sympathetic Ganglion Neuron-cardiomyocyte co-cultures. Primary cultures of cardiac 
ventricular myocytes (CMs) were prepared from 1- to 2-day-old Sprague Dawley rats as 
previously described. Briefly, hearts were removed, minced in ADS (106 NaCl, 5.3 KCl, 
20 Hepes, 0.8 Na2HPO4, and 0.4 MgSO4, in mM) and enzimatically dissociated with 
collagenase A (0.4 mg/ml) (Roche) and pancreatine (1.2 mg/ml) (Sigma). Sympathetic 
neurons (SNs) were isolated from 1- to 3-day-old Sprague Dawley rats by adapting the 
procedure of Zareen and Greene [Zareen, 2009 #1]. Both superior cervical ganglia were 
minced in complete medium (RPMI supplemented with 10% Horse Serum (HS), both 
Invitrogen) and then enzimatically dissociated in 0.5% Trypsin with no EDTA 
(Invitrogen) for 30 min at 37°C. CMs and SNs were seeded at a density of 60000 cells/cm2 
and 1500 cells/cm2, respectively. Cells were plated onto laminin-coated (10 µg/cm2)  
round glass coverslips in cardiomyocyte medium (75% D-MEM-Hepes, 17% M199, 5% 
horse serum, 0.5% newborn calf serum, 200 mM glutamine, penicillin-streptomycin, all 
from Invitrogen) supplemented with 100 ng/ml NGF (Sigma) and maintained in a 
humidified atmosphere (5% CO2) at 37°C. Half of the medium was replaced every two 
days.  
To achieve expression of the FRET-based biosensors in CMs, cells plated on glass 
coverslips were transfected with Transfectin Reagent (BioRad) following manufacturers’ 
instructions prior to SN plating.  
 
Immunofluorescence on SN-CM co-cultures. SN-CM co-cultures were fixed in 4% 
paraformaldehyde (PFA) (Sigma) for 30 minutes at 4°C temperature, and processed for 
immunofluorescence analyses. Cells were permibilized with 0.1% triton-X100 at room 
temperature, incubated with primary antibodies diluted in PBS supplemented with 1% 
BSA 2 hours at 37°. The following primary antibodies were used in this study: rabbit anti-
flag (1:800, Sigma); mouse anti-HA (1:800, Roche). FITC- and Cy3-conjugated secondary 
antibodies, all from Jackson lab (UK), were used to detect primary antibodies.  
 
Transient transfection of cardiomyocytes. Cardiomyocytes were transient transfected 
with TransFectin Lipid Reagent (Bio-Rad). Cells were transfected the day after seeding. 
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For 6 well plate 3 µg of DNE are put in 250 µl of M199 (GIBCO, invitrogen), incubated 5 
minutes at room temperature. Meanwhile 5 µl of transfectine are put in 250 µl M199, and 
incubated 5 min at room temperature. DNE solution and transfectine solution were 
combined and incubated 20 minutes at room temperature. Cells were washed once with 
ADS (106 NaCl, 5.3 KCl, 20 Hepes, 0.8 NaHPO4, 0.4 MgSO4, in mM), and 500 µl of 
cardiomyocyte medium was added. The DNA-transfectin mix was added drop by drop to 
the cells and let incubate 4 hours in a humidified atmosphere (5% CO2) at 37°C. 
 
Fluorescent Resonance Energy Transfer (FRET) measurement. Cardiomyocytes were 
transfected with a plasmid that express EPAC1 or AKAR3 for 7 days. Cells were rinsed 
and maintained in a Ringer-modified saline (125 mM NaCl, 5 mM KCl, 1 mM Na3PO4, 1 
mM MgSO4, 5.5 mM glucose, 1.8 mM CaCl2, 20 mM Hepes, pH 7.4) for FRET 
recording. Cells were imaged on an inverse fluorescent microscope (IX50, Olympus) 
coupled to a CCD camera (Sensicam QE, PCO) and a beam-splitter optical device 
(Microimager). Images were acquired using custom-made software and processed using 
ImageJ (National Institutes of Health). 
Dual emission ratio was acquired with a 436 nm excitation filter,  and emission filter (535 
nm). The acquisition was set at 500 millisecond of exposure every 5 second of acquisition. 
Background was subtracted to the images and the ratio of yellow-to-cyan was calculated at 
different time point. After PKA activation the ratio YFP/CFP displayed increases, on the 
contrary after EPAC1 activation the ratio YFP/CFP displayed decreases. FRET values 
were expressed as ∆R/R0, where R0 is the ratio at t = 0 s and ∆R = R - R0. 
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Discussion 
 
The catecholaminergic neurons innervating the heart are responsible for the continuous 
adjustment of cardiac performance, through activation of β-ARs, occurring in both the 
daily activities and in acute stress as part of the fight-or-flight response. It is generally 
accepted that neuro-muscular coupling takes place at multiple interaction sites between the 
NE-releasing varicosities along the neuronal axon and the target cardiomyocytes. Recent 
work performed in vitro on co-cultures of sympathetic neurons and cardiomyocytes 
demonstrated that the junctional site between the two cells [6] is characterized by 
specialization of both the pre- and post-synaptic membranes. However, the functional role 
of the apposition of the two membranes in signal transmission from the adrenergic neuron 
to the cardiomyocyte remains largely unexplored.  
Here, we used state-of-the art live cell FRET-imaging of cAMP and PKA in sympathetic 
neuron-cardiomyocyte co-cultures to investigate the dynamics of β-adrenergic signaling at 
the neuro-cardiac junctional sites. We demonstrate that the synaptic cleft forms a 
diffusion-limited space allowing NE release to rapidly achieve a concentration sufficient 
to fully activate β-AR dependent signaling, leading to cAMP elevation and PKA 
phosphorylation. These results support the concept that neurogenic control of 
cardiomyocyte function takes place through the direct cell-cell contact, and identifies the 
neuro-cardiac junction as the unitary functional element in the autonomic control of 
cardiac performance.  
 
Activation of the cardiac sympathetic neurons enables physiologic enhancement of 
contractility in response to increased perfusional demand from the tissues. Transmission 
of the signal from the post-ganglionic catecholaminergic neurons to cardiomyocytes is 
mediated by NE, which acts on sarcolemmal β-AR. Activation of β-AR increases cAMP 
synthesis, causing PKA to phosphorylate its downstream targets, including Ca2+-
regulating proteins that increase sarcomere shortening rate and force generation.  
We implemented co-cultures of sympathetic ganglia neurons and neonatal cardiomyocytes 
as in vitro model to study the neuro-cardiac signaling axis. Neurons extend their axons in 
culture and develop multiple varicosities in series that connect with contractile 
cardiomyocytes (FIG. 1A). This model essentially reproduces the morphological features 
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of cardiac sympathetic neurons, which innervate densely the myocardium and interact 
with multiple cardiomyocytes as shown in figure (FIG 1C, 1D) and in Zaglia et al. , 
Cardiovasc Res. 2013 [18]. Sympathetic neurons in the co-culture exhibited low frequency 
spontaneous action potentials, as previously reported, and responded to transient 
membrane depolarization with a rise in [Ca2+] (FIG. 2B, 2C). Cardiomyocytes formed 
a syncytium and had rhythmic spontaneous contractions. We thus used the FRET 
based biosensors sensing cAMP (EPAC1cAMPs) [17] and PKA activity (AKAR3) [19] to 
image activation of the β-AR dependent pathway. These biosensors were extensively 
tested by several groups including ours.  
The high spatial resolution of such optical technique allowed assessing signal transmission 
between the neuron and the coupled cardiomyocytes at the level of the single axonal 
varicosity and in real time. Stimulation of catecholamine release by a given neuron 
activated β-AR on cardiomyocytes in contact with the axonal releasing sites, causing a fast 
and transient elevation in both intracellular cAMP and PKA activity. The neuronal signal 
was only detected in cardiomyocytes directly interacting with axonal boutons, and was 
absent in the neighbouring cells (FIG. 2E, 2F, 2D). These data indicate that the neuro-
cardiac junction is the functional signaling unit of sympathetic neuron/cardiac cell axis. 
This concept is well supported by the observation that at the junctional site the 
cardiomyocyte membrane shows clustering of structural proteins and β1-AR [20] and 
[Franzoso, ms in preparation], and in agreement with this, the cAMP response evoked by 
the neuronally released NE was mainly attributable to β1-AR activation (FIG. 4C). It is 
becoming increasingly evident that β1 and β2-AR have a different functional role that is 
believed to depend on selective distribution of the receptors on the cell membrane [6], 
causing spatial patterning of intracellular signals, including cAMP [21]. It is tempting to 
speculate that the selective localization of β1 AR in proximity to the neuronal release site 
represent the structural basis ensuring differential β1-AR vs β2-AR activation by 
neuronally-released or circulating catecholamines, respectively (27).  
We used a propranolol competition-binding assay to estimate [NE] in the cleft, which 
resulted in the order of 100 nM, indicating that the intermembrane space in which NE is 
released generates a diffusion-restricted extracellular domain. Thus, thanks to the direct 
and organized contact, neuronal stimulation leads to activation, at about half potency, of 
the β-AR pool localized at the junctional site. Ultrastructural definition of the membrane 
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apposition at the junctional site is outside the scope of the present work, however it has 
been demonstrated that in cholinergic neuro-muscular junuction, the intermembrane space 
is in the order of 50-80 nm with only a single layer of basal lamina separating the two 
structures [22] and we found comparable distances in EM images of co-cultured 
sympathetic neuron/cardiomyocytes [Franzoso, ms in preparation]. This model has several 
functional implications: first, the very low volume of the intermembrane space allows to 
achieve [NE] in the micromolar range with only very few thousands molecules (i.e. few 
vescicles) released in the cleft; furthermore, this structure allows efficient signaling to the 
receptors, as supported by simulation models showing that as the minimal distance of the 
varicosity-to-muscle apposition increases from 50 nm to 200 nm, the number of activated 
receptors in the post-junctional membrane decreases by about 90% [23]. In addition, direct 
neuron to cardiomyocyte coupling minimizes diffusion time after secretion of NE, 
allowing immediate activation of cardiac β-AR responses. This model is in good 
agreement with the observation that several downstream molecules of the β-AR signaling 
pathway, including cAMP generating adenylate cyclases, PKA and its targets involved in 
E-C coupling (i.e. L-type Ca2+-channels) are tethered through scaffold proteins (i.e. 
AKAPs) in close proximity to the receptor. Interestingly, clustering of such proteins has 
been observed at the junctional site [6]. Both the efficiency and velocity of signal 
transmission of the neuro cardiac coupling are unconditional requirements for the beat-to-
beat control of cardiac function by the autonomic reflexes.  
Dysregulation of the neurogenic control of cardiac function, leading to unbalanced 
sympathetic input to different regions of the heart, has been correlated to arrhythmia 
triggering [10]. The concept that sympathetic imbalance has arrhythmogenic potential has 
been suggested a few decades ago [10] , and demonstrated since then in a number of 
pathologic states [12, 24, 25]. Regional differences in sympathetic discharge have been 
associated with arrhythmias in both ischemic hearts and structurally normal hearts of 
arrhythmic patients. The mechanism whereby regional heterogeneity of sympathetic 
discharge causes arrhythmia is associated with AP dispersion, an electrophysiological 
state favouring ventricular arrhythmias. To date, the mechanisms of regional control over 
cardiac activity by specific groups of cardiac sympathetic terminals are largely unexplored 
in both physiological and pathophysiological states.  
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Moreover it has been suggested that stimulation of a limited region of the cells by NE is 
sufficient to trigger a premature ventricle complex [14], suggesting that the unbalanced 
SN neurons activity could lead to a depolarization in a limited group of cells that 
represents the critical mass sufficient to trigger a premature ventricle beat. 
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In the first part of my PhD I started working with ChR2 and analyzed the 
structure/function relationship of the protein using a bioinformatic model, in combination 
with site directed mutagenesis and electrophysiology. 
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Optogenetic control of sympathetic neurons activity in vitro and in vivo 
 
ChR2 photostimulation modulates activation of neuronally differentiated chromaffin 
cells 
 
The aim of this part of the project is to develop an optogenetic approach to control 
sympathetic neuron activity with high temporal resolution and non invasively, by using 
ChR2. ChR- microbial proteins are light-gated channel and they were extensively used to 
control the activity of excitable cells [4, 5, 70, 80]. Among these light-controlled protein, 
ChR2 is a plasma-membrane localized protein that becomes permeable to cations (mostly 
Na+) upon light stimulation at 470 nm [68]. This tool has been used also to modulate 
neuronal activity in vivo, indeed photostimulation of ChR2 trigger a depolarization 
sufficient to induce action potential in neuronal cells [5, 70].   
To test in vitro the feasibility of such approach, we used co-cultures between neuronally 
differentiated chromaffin (PC12) cells and neonatal cardiomyocytes (FIG 1A).   
PC12 cells are pheochromocytoma cell line that acquires a neuronal phenotype in presence 
of NGF and low concentration of serum [81], and they are able to secrete acetylcholine 
and NE upon depolarization-induced intracellular Ca2+ increase [81, 82]. PC12 cells were 
transiently transfected with a plasmid encoding the H134R variant of ChR2, a variant 
engineered to maximize current amplitude in response to light-induced depolarization [83]. 
To assess whether ChR2 induced a depolarization sufficient to stimulate Ca2+ influx in the 
PC12 cells, we used fluorescence Ca2+ imaging with FURA2-AM (Molecular Probes, 
invitrogen U.S.A). Differentiated PC12 were loaded with Fura2-AM and placed on the 
stage of a fluorescence microscope. Photostimulation with 200 ms pulse trains, at 460 nm 
caused a rapid intracellular Ca2+ increase (∆R= 40% ± 3%) in ChR-positive cells with no 
effect on intracellular Ca2+ in cells not expressing ChR2 (FIG. 1B). 
To verify whether optogenetic modulation of neuronal-differentiated PC12 cells can 
modulate cardiomyocyte activity, we test whether stimulate of ChR2-positive PC12 cells 
can modulate cardiomyocyte beating rate. 
We loaded PC12/cardiomyocytes co-cultures with the intracellular Ca2+ indicator FURA2-
AM. Neonatal cardiomyocytes contract spontaneously and display spontaneous 
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intracellular Ca2+ oscillation and respond to NE activation of β-ARs [84], with an increase 
of the spontaneous beating rate.  
In ChR2-expressing PC12 coupled to a cardiomyocyte (FIG. 2A) the frequency of 
spontaneous Ca2+ transients increased significantly. This suggests that photostimulation of 
ChR2 induces a depolarization sufficient to trigger NE release, that interacts with the β-
ARs localized in the plasmamembrane of the cardiomyocyte (FIG 2B). 
These data suggest that the ChR-mediated control of sympathetic neurons is a feasible 
method to modulate the contraction frequency of cardiac cells, and could be also applied 
to modulate heart beating rate in living mice.  
 
ChR2 photostimulation of SNS increase heart beating rate in vivo 
 
SN depolarization lead to NE release from sympathetic nerve endings activated β-ARs 
leading to increase in the heart beating rate. Here, we provided a novel approach to 
optically depolarize neuronal-like cells inducing increase in the cardiomyocytes beating 
rate in vitro.  
We used optogenetics with ChR2 to develop an experimental model for non-invasive 
control of cardiac sympathetic neurons. Transgenic mice expressing ChR2 in the 
sympathetic ganglia neurons were obtained by breeding double floxed-ChR2-mTomato 
mice (Jackson Lab) with a strain expressing Cre-recombinase driven by the adrenergic 
neuron specific tyrosine hydroxilase (TOH) promoter. The offsprings were genotyped and 
mice with expression of both alleles were analyzed by fluorescence microscopy. 
Successful recombination of the floxed ChR2 gene was demonstrated by expression of 
mTomato fluorescence in the superior cervical ganglia neurons (FIG. 3A). Superior 
cervical ganglia were harvested and fixed in PFA (4%), and cryo-sections were obtained 
in frozed, OCT cast samples. Fluorescence microscopy analysis showed that ChR2 is well 
expressed in the superior cervical ganglia and it is localized correctly in the 
plasmamembrane of the cells (FIG. 3B).  
Function of ChR2 was determined using optical stimulation of the cervical sympathetic 
chain neurons and in the stellate ganglia, by delivering fast (10ms) light pulses (470nm) 
with a fiber optic during continuos ECG monitoring. 
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Mouse was anesthetized with a combination of tiletamine/zolazepam and xylazine, 
ventilated to allow surgical access of the deeper plans of the neck and the thorax. The 
mouse was connected to an ECG apparatus (FIG. 4). Fiber optics of different size 
(Thorlabs, 200µm to 1 mm diameters) were positioned at different points in the cervical 
sympathetic chain and both stimulation of the superior cervical ganglia and stellate ganglia, 
containing most cell bodies of the postganglionic sympathetic neurons projecting to the 
heart.  
Stimulation of the left stellate ganglia with bursts of 10ms long pulses at 30Hz rate, we 
lead to an immediate increase in HR which averaged 40% in 10 different trials 
(∆(HRbasal/HRstim): 41% ± 6%) (FIG. 5A). Interestingly, the method allowed to assess the 
response time of the SA node upon photoactivation of the neurons, and we found that a 
significant increase in HR was evoked after as few as 3-4 light pulses. Thus, the activation 
time was in the range of 90-120ms.(FIG. 5B). During this time, the series of events 
occurring from neuronal AP to increased automaticity in the SA cardiomyocytes must 
include: the activation of vesciclular NE release, its diffusion to the cardiomyocyte 
membrane, interaction with β-AR, activation of cAMP synthesis and PKA 
phosphorylation of pacemaker channels.  Of all these steps, agonist dependent β-AR 
activation has been shown to require about 50ms, the subsequent cAMP synthesis likely 
requires even more time. This implies that time of NE diffusion from the neuron to the 
cardiomyocyte is in the order of few ms.  
This result is therefore in support of the hypothesis that the sympathetic-releasing 
terminals are in direct contact with the ‘postsynaptic’ cardiomyocyte membrane. 
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Materials and Methods 
Transgenic mice. Transgenic mice expressing cre-recombinase under the control of 
Tyrosine Hydroxilase (TOH) promoter were bred with B6.Cg-Gt (ROSA) 26Sortm27.1 
(CAG-COP4*H134R/tdTomato) Hze/J expressing mice (Jackson Lab. Bar Harbor, Maine, USA). The 
resulting offspring has the STOP cassette deleted in the neurons, resulting in SN 
expression of the hChR2 (H134R)-tdTomato fusion protein. All experimental procedures 
described in this manuscript have been approved by the local ethical committee and 
communicated to the relevant Italian authority (Ministero della Salute, Ufficio VI), in 
compliance of Italian Animal Welfare Law (Law n 116/1992 and subsequent 
modifications). 
 
Tissue samples and confocal image analysis. The sympathetic ganglia neurons has been 
harvested from TOHcre/loxPChR2 transgenic mice, as well as control mice, fixed in 2% 
paraformaldehyde (PFA) (Sigma) for 15 minutes at room temperature, equilibrated in 
sucrose gradient at 4°C, frozen in liquid nitrogen. Ten-micron ganglia sections have been 
obtained with a cryostat (Leica cardiomyocyte1850, Leica Microsystems GmbH, Wetzlar, 
Germany) and processed for histological and immunofluorescence analyses. Sympathetic 
ganglia sections have been analyzed at the confocal microscope Leica SP5. 
 
In vivo stimulation of ChR2 expressing SGN. Mice have been anesthetized, intubated 
and ventilated as previously described. Stellate ganglia have been exposed and different 
areas have been stimulated fiber optic of different size (from 200 µm to 1 mm of diameter) 
powered by a LED emitting light at 470 nm (470nm LED, 1, 5 A, Thorlabs). ECG 
recording and LED control have been performed with an ECG-recording system 
(Powerlab 8/30, Bioamp and Chart 7.1 software; AD Instruments). Duration of P-waves, 
PQ intervals and QRS complexes have been evaluated with Chart software and ECG 
analysis module (AD Instruments). 
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Optical modulation of AP in cardiac cells  
 
Preliminary result 
 
In the first part of the ChR2-based study of the electrophysiological modulation of heart 
activity by light, we tested the feasibility of the method using rat neonatal cardiomyocytes 
culture as in vitro model.  
 
Optical control of cardiomyocytes activity by ChR2 photostimulation in vitro 
 
Recently optogenetic strategy has been used not only to modulate neuronal activity[1-4] 
but also to control with millisecond resolution the heart rate in vitro and in vivo [5].   
Depolarization of cardiac cells triggers the opening of the L-type Ca2+ channels that are 
the initial event for the CICR process that is involved in the heart contraction. 
We wanted to optically modulate the heart activity with high temporal precision and in 
non invasive way in living mice. To test the feasibility of the methods we test the ChR-
based approach in cardiomyocytes isolated from neonatal rats. We expressed the gene 
encoding for ChR2(H134R) variant fused with a fluorescence protein (EYFP) by transient 
transfection in rat neonatal CMs.  
By whole cell patch clamp recording we monitored the action potential (AP) in the cardiac 
cells to verify whether we were able to modulate cardiac activity by light. We stimulated 
ChR2 expressing CM with an LED emitting light at 470 nm, during the AP recording. CM 
contract spontaneously, and we observed that depending on when the light pulses was 
given we were able to trigger or a delay after depolarization (DADs), an early after 
depolarization (EAD) or a normal beat. If the light pulses was given before the ending of 
the repolrarization we trigger an EAD, on the contrary if we stimulated the cells before the 
beginning of the depolarization we trigger a DAD.  
It has been shown that asynchronous oscillation in the AP are involved in the arrhythmias 
triggering, indeed it has been shown that the triggering of arrhythmic events could be 
DAD or EAD. 
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Because the fact that  AP activation trigger the opening of the voltage-gated Ca2+ channel 
leading to the increase in the intracellular Ca2+ , we assessed cytosolic Ca2+ variation in 
ChR2 expressing cells upon stimulation with light at 470 nm. To monitor the variation of 
the concentration of the intracellular Ca2+ we loaded the cells with the Ca2+ indicator 
FURA2-AM (2.5 µM, 30 min). In a CM expressing the ChR2 protein we activate the 
action potential and we monitor intracellular Ca2+ variation.  
We observed intracellular Ca2+ increase in cells expressing ChR2 upon optical stimulation 
with blue light, demonstrating that ChR2 phostostimulation induces an AP sufficient to 
open the voltage-gated Ca2+ channel triggering the CICR process. It is interesting to notice 
that the Ca2+ diffuses through the adjacent cells. Indeed upon stimulation of ChR2 
expressing cells, intracellular Ca2+ increases and monitoring Ca2+ variation in the adjacent 
cells, we observed Ca2+ variation in the non-transfected adjacent cells. This event could be 
explained by the fact that CM are electrically connected one to the other with the gap 
Junction, allowing the passage of the AP originated in the ChR2 expressing cells also to 
the neighboring cells, leading the opening of the Ca2+ channel and as consequence 
intracellular Ca2+ increase also in the non-transfected cells.   
Here we have been provided preliminary data showing that optical activation of ChR2 is a 
useful method to modulate action potential and Ca2+ transient in cardiac cells. We used 
this approach to calculate the fraction of asynchronous cells needed to trigger an 
arrhythmic event.  
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FIGURE 1 
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FIGURE 2 
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Optogenetic interrogation of the arrhythmic mechanisms in the early 
phase of myocardial ischemia 
 
Abstract 
 
Lethal ventricular arrhythmias, including sustained ventricular tachycardia (VT) and, in 
particular, ventricular fibrillation (VF) during the early phase of myocardial infarction, are 
the immediate cause of sudden cardiac dead (SCD). 
Experimental studies indicate that ischemia- or infarction-induced heterogeneities in 
excitability, refractoriness and/or conduction create the substrate and that ectopic 
excitation by a variety of mechanisms may provide the extrasystoles that trigger lethal 
ventricular arrhythmias. 
We have implemented a novel arrhythmia assay exploiting cardiac photostimulation of 
ChR2-expressing hearts. The method uses a fiber optic to deliver time controlled pulses of 
470nm light to the epicardial surface in an open-chest anesthetized mouse.  
We optically stimulate both the right atria (RA) and the ventricle. RA stimulation triggers 
increase in the heart rate, on the contrary photostimulation of 100 µm x 100 µm wide 
region epicardial region trigger a premature ventricle complex (PVC).  
 We triggered VT in a pro-arrhythmic condition such as AMI. We triggered sustained VT  
by stimulating peri-infarct area, observing an increase in the refractoriness to 
depolarization. 
 This novel approach allow us to calculate the critical mass necessary to trigger a 
premature ventricle beat in the order of 50 cells. Depolarization of such limited region is 
sufficient to trigger a sustained ventricular fibrillation  in the early phase of acute 
myocardial ischemia. 
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Introduction 
 
Lethal ventricular arrhythmias, including sustained ventricular tachycardia (VT) and, in particular, 
ventricular fibrillation (VF), are the immediate cause of cardiac arrest in most of the estimated 
300,000 to 350,000 cases of sudden cardiac death (SCD) that occur annually in the United States 
of America (USA) [6, 7]. A major cause of SCD is coronary artery disease,  during both the acute 
ischemic phase and during the infarct evolution phase. AMI induced-VF leads to SCD as the first 
manifestation of a preexisting coronary artery disease in about 80,000 people per year [6, 7]. 
Experimental studies indicate that ischemia- or infarction-induced heterogeneities in excitability, 
refractoriness and/or conduction create the substrate and that ectopic excitation by a variety of 
mechanisms may provide the extrasystoles that trigger lethal ventricular arrhythmias[8].  
Many SCDs from VT/VF occur during acute myocardial ischemia [8]. Abrupt cessation of 
myocardial blood flow causes Ionic imbalances across the cardiomyocyte membrane, 
including H+, Na+, Ca2+ and K+, with altered function of ion channels and transporters. In 
the vast majority of cases, Phase 1A arrhythmias appear to arise from reentry and manifest as 
bursts of VTs that rarely evolve into VF. In contrast, Phase 1B arrhythmias may emerge from 
both focal as well as non-focal sources and both abnormal automaticity as well as reentry may 
take place. Conceivably, a combination of the higher propensity to generate Ca2+ 
dependent DAD and the increased electrical resistance between cardiomyocytes in the 
acutely ischemic myocardium are the initiating events of conducted extra beats [9].  
The factors that determine whether a DAD results in a propagating action potential in the 
setting of acute myocardial ischemia. Although spontaneous Ca2+ waves occur in buffer-
perfused isolated heart preparations under physiological conditions as well as following 
injury [10-13], it is not known whether Ca2+ waves trigger arrhythmias under ischemic 
conditions because reduced intercellular coupling would diminish the opposing, i.e. 
repolarizing, effect of passive outward current generated by neighboring cardiomyocytes. 
The critical mass of cells necessary to generate a conducted beat has not been identified 
directly. Simulation modeling indicates that in the intact non-ischemic myocardium the 
minimal myocardial tissue volume that needs to simultaneously depolarize to generate an 
extra beat is in the order of 800.000 cells.  
One of the experimental ways to address selectively the mechanism of propagation of 
DAD and EAD uses timely and spatially controlled electrical pulses to assess the 
vulnerability to AP propagation in the tissue [14]. However, this system lead to production 
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of toxic gases, such as H2, O2 or Cl2 and modification in the pH . Thus this kind of 
approach could be used only for brief depolarization that trigger AP and not for prolonged 
stimulation.  
Thus our aim is to used optogenetic approach to modulate non invasively and in alimited 
region of the heart the AP of the cardiac cells. 
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Optical control of heart rate by ChR2 photostimulation in living mice 
 
 
We have implemented a novel arrhythmia assay capable of high spatial resolution and 
temporal accuracy, that uses cardiac photostimulation of ChR2-expressing hearts. The 
methodology allowed to determine the critical tissue mass and the vulnerability to 
generate sustained VT/VF in the normal myocardium and during acute myocardial 
ischemia.   
ChR2 is a photoactivatable microbial derived cation channel, mostly permeable to Na+. Its 
structural similarity with rhodopsin confers the proteins the property of undergoing a 
conformational change upon illumination, which results in the immediate change of ionic 
permeability [15]. ChR2 exhibits fast temporal kinetics (in the order of ms) that make it 
possible to drive reliable trains of high frequency action potentials in vivo [2, 16]. ChR2 
has mostly been used in neurons allowing optical 'interrogation' of a specific neural circuit 
in vivo [3], and it has been shown to work in other excitable tissues including the 
myocardium.   
To achieve ChR2 expression in cardiac cells, we crossed  B6.Cg-Gt (ROSA) 26Sortm27.1 
(CAG-COP4*H134R/tdTomato) Hze/J expressing mice with mice expressing Cre recombinase under 
control of the cardiac αMHC promoter.  The resulting offspring has the STOP cassette 
deleted in the heart, resulting in expression of the hChR2(H134R)-tdTomato fusion 
protein, which localizes in the cardiomyocyte membrane as expected (fig 1A). The hearts 
had normal histology (fig 1B) with unchanged HR and function when compared to 
Cre+/ChR2- or Cre-/ChR2+ or normal controls. 
 
A fiber optic was used to deliver time controlled pulses of 470 nm light to the epicardial 
surface in open-chest anesthetized ChR2 mice. Placement of the fiber tip through a 
micromanipulator under stereo-microscope guide allowed photostimulation of a spatially 
defined region of the heart. During the experiment, the cardiac activation sequence is 
continuously monitored through surface ECG, and online detection of R-waves allows to 
regulate timing of the light pulses with respect to the spontaneous QRS.  
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Epicardial illumination with a time controlled pulse of light at 470nm was effective in 
depolarizing a confined area of myocardium. Atrial pacing from both RA and LA was 
obtained at rates up to 900 bmp, (5ms light pulses delivered at 15Hz) (preliminary data 
FIG. 1C), demonstrating that spatially regulated stimulation of the atria was achieved.  
Consistent with previus report [5] the delay between the light pulse and the ECG respose 
in the atria is 13.5 ms ± 5.6 (mean ±SEM, n=6) and the delay from the light pulse to the 
onset of the ventricle extrabeat is 9.4 ms ± 0.5 ms (mean ± SEM, n=9). 
We used differently-sized fibers (from 200 µm to 700 µm core size) for ventricular 
photoactivation analyzing the probability to generate a PVC (FIG. 1D) to determine the 
critical myocardial mass to generate a globally spreading depolarization wave.  
We observed that stimulation of  100 µm x 100 µm wide area is sufficent to conduct light-
induced beats to the whole heart, increasing the capture efficiency with the enlargement of 
the stimulated areas, reaching the maximum with the 700 µm sized fiber ( FIG 2A). Thus 
we determined that photoactivation was achieved in a region corresponding to around 50 
cells of the first epicardial layer (FIG. 2B). Because the fact that fiber optic drive light 
deep in the tissue we estimated the volume of the cells activated by light considering a 
depth of 200 µm and with a 100 µm x 100 µm wide region. In this condition the volume 
of cardiac cells depolarized by light is 0.010 mm3. 
The surface threshold of myocardial photostimulation was evaluated with respect to the 
latency of the light pulse from the preceeding QRS. Within 40 ms from the R-wave onset 
(which would correspond to EAD events, the probability of generating a PVC and the 
minimal critical tissue mass higher when compared to pulses falling in the diastolic phase, 
mimicking the effect of a DAD.  
We test optogenetic approach also in a pro-arrhythmic condition such as AMI. Indeed it 
has been demonstrated that the risk of ventricular fibrillation is common in the early phase 
of acute myocardial infarction [17, 18]. 
Acute coronary ischemia was obtained by legating the left anterior descendant (LAD) 
coronary artery [19] during continuous ECG monitoring. The tributary myocardium 
became immediately pale and within the first ten minutes, ischemia caused alteration in 
the QRS complex and amplitude, with only rare ectopic ventricular beats. Injured area size 
was confirmed by using tatrazolium staining as shown in figure FIG. 3A.  
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Photostimulation was obtained with 1s bursts of pacing flashes on the left ventricle at the 
infarct border zone and in the right ventricle close to the right ventricular outflow tract 
(RVOT). Stimulations evoked monomorphic VT, that had a capture ratio of about 1:1.3 at 
frequencies up to 20 Hz compare to 1:1 of the control, indicating that the refractoriness to 
depolarization increased during phase 1A of ischemia.  
After 15-30 min of ischemia, burst photostimulation evoked frequent episodes of 
ventricular flutter and rare VF, which terminated promptly at the end of pacing , with a 
pause to the subsequent beat. Stimulation of the RV caused the pacing-evoked VT to be 
sustained after pacing cessation, frequently lasting a limited number of beats . At 
frequencies 16-25 Hz, burst stimulation triggered frequently sustained polymorphic 
VT/VF lasting 8-50 s  (FIG. 3B), which was highly reproducible in the same heart, but 
differed in optimal train rate and illumination position among different experiments. 
To conclude, we calculated the critical mass necessary to trigger a PVC was around 0.01 
mm3 that are less than 1000 cells. Moreover we observed that the refractoriness to 
depolarization of in the acute phase of myocardial ischemia is increased and light induced 
DADs in a 100 µm x 100 µm wide area is sufficient to trigger a sustained VT. 
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Material and Methods 
 
Transgenic mice. Transgenic mice expressing cre-recombinase under the control of 
alpha-Myosin Heavy Chain (α-MHC) promoter were breeded with B6.Cg-Gt (ROSA) 
26Sortm27.1 (CAG-COP4*H134R/tdTomato) Hze/J expressing mice (Jackson Lab. Bar Harbor, Maine, 
USA). .  The resulting offspring has the STOP cassette deleted in the heart, resulting in 
cardiac expression of the hChR2(H134R)-tdTomato fusion protein. All experimental 
procedures described in this manuscript have been approved by the local ethical 
committee and communicated to the relevant Italian authority (Ministero della Salute, 
Ufficio VI), in compliance of Italian Animal Welfare Law (Law n 116/1992 and 
subsequent modifications). 
 
Tissue samples and confocal image analysis. The heart has bee harvested from 
αMHCcre/loxPChR2 transgenic mice, as well as control mice, fixed in 2% 
paraformaldehyde (PFA) (Sigma) for 15 minutes at room temperature, equilibrated in 
sucrose gradient at 4°C, frozen in liquid nitrogen. Ten-micron myocardial sections have 
been obtained with a cryostat (Leica CM1850, Leica Microsystems GmbH, Wetzlar, 
Germany) and processed for histological and immunofluorescence analyses. Heart sections 
have been analyzed at the confocal microscope Leica SP5. 
 
 
Myocardial infarction. Adult transgenic and control mice have been anesthetized either by 
isofluorane (1.5% O2) or Avertin administration (250mg/kg i.p.) and fixed in the supine position.  
Mice have been intubated with a 24G needle and ventilated with room air (tidal volume 0.4ml; 
120 strokes/min) using an artificial ventilator (SAR-830) and both temperature and respiratory 
rate have been monitored constantly. The skin has been dissected by a lateral 1.5 cm cut at the 
sub-ascellary region. The subcutaneous muscles have been removed and a 0.5 cm incision have 
been performed at the level of the fourth intercostal space. Self-retaining microretractors have 
been then used to separate the 3rd and 4th ribs enough to get adequate exposure of the operating 
region, but the ribs were kept intact. The left ventricular wall has been exposed and once 
identified, the main trunk of the left descending coronary artery has been ligated by using a 7/0 
polypropylene suture.  
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Calculation of critical mass of cardiac cells. Mouse heart was harvested and loading with the 
mitochondrial dye TMRM (xxx) and was examined at confocal microscope  
 
Triphenyl-Tretrazolium staining. Hearts have been removed four hours upon myocardial 
infarction. Two mm myocardial slices have been stained in 1% tetrazolium (Sigma) in 
phosphate buffer at 37%  for 20 min. at 37°C. The slices have been washed in the buffer and 
images of the sections have been taken with a xxx camera for later analysis of infarct size.  
 
Photoactivation of the myocardium and ECG recording in anesthetized mice. Mice 
have been anesthetized, intubated and ventilated as previously described. Hert have been 
exposed and different areas have been stimulated with a fiber optic of different size ( from 
200 µm to 1 mm of diameter) powered by a  LED emitting light at 470 nm (470nm LED, 
1,5 A, Thorlabs). ECG recording and LED control have been performed with an ECG-
recording system (Powerlab 8/30, Bioamp and Chart 7.1 software; AD Instruments). 
Duration of P-waves, PQ intervals and QRS complexes have been evaluated with Chart 
software and ECG analysis module (AD Instruments). 
 
Statistical analysis. All data are expressed as the mean±s.e.m. Comparison between the 
experimental groups has been performed by using the non-paired Student’s t and Anova 
tests with P<0.05 being considered statistically significant. 
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FIGURE 2 
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FIGURE 3 
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SUPPLEMENTARY DISCUSSION AND CONCLUSION 
 
In the first part of this work, using SN-CM co-cultures as in vitro model, we have been 
provided evidence of the existence of a restricted and specialized domain between SN and 
CM with high concentration of NT. Previous studies have only been speculate on the 
existence of the synaptic interaction between SN and CM [43-46], without any specific 
demonstration of the functional role of this close relation in the CM intracellular signalling. 
Here we have been used a FRET-based approach in order to monitor β-ARs activation 
upon SN stimulation mimicking the release of NE during the flight or fight response. The 
evidence of the existence of synaptic connections between SN and CM are the following: 
(a) SN stimulation induces increase in the intracellular cAMP and PKA activity only in 
the innervated CM. (b) Perfusing SNs with the stimulation solution we washed away the 
aspecific release of NE, observing the response only due to the NT acting in a confined 
domain. Activation of SN with the bathing solution triggers the response only in the target 
cells. (c) Using the non specific β-blocker propranolol (PROPR.) we showed that the 
[PROPR.] needed to block the SN-induced response is higher than that needed to abolish 
the response induced by 3.5e-10 M of NE which trigger a FRET variation similar to that 
induced by SN. This implies that NE released act in a domain in which the concentration 
is high and it is not aspecifically dilute in the medium.  
The existence of a synaptic connection between SNs and the CMs is important in the 
studying of arrhythmic event. Indeed it has been suggested that unbalanced SN discharge 
is a cause of arrhythmic event in healthy and diseased heart[50], and it has been shown 
that NE spillover leads to arrhythmic event in the failing myocardium[52]. In addition 
recently it has been suggested that stimulation of a limited region of the cells by NE is 
sufficient to trigger a premature ventricle complex [56]. Taking into account all this 
consideration the existence of synaptic contact between SN and CM, suggests that the 
unbalanced impairment in the SN could lead to a depolarization in a limited group of cells 
that represents the critical mass sufficient to trigger a premature ventricle beat. 
Indeed, the aims of the second and the third parts of the work are to investigate on the role 
of the SNS in the arrhythmias triggering, and to understand which is the critical mass 
98 
 
necessary to induce a premature ventricle beat in vivo. We based our strategy on the ChR-
microbial proteins, in particular ChR2 that is a light gated cation channel, becoming 
permeable mostly to Na+ upon light stimulation at 470 nm[68]. Using transgenic mice 
expressing ChR2 in adrenergic neurons we were able to increase heart contraction rate non 
invasively and with millisecond resolution in vivo. We showed that increasing in the heart 
frequency occurs after 100-150 ms from light stimulation, supporting the hypothesis of the 
existence of SN-CM synapses.  
Using another model of transgenic mice that express ChR2 in the cardiac cells we are 
investigating on the critical mass necessary to trigger an arrhythmic event. We were able 
to increase the heart rate by pacing a limited region of the atria (from 200 µm to 1 mm, 
diameter). Moreover photostimulating a region of 200 µm of diameter in the ventricle we 
were able to trigger a premature ventricle beat, suggesting that depolarization of 100 x 100 
mm wide region of epicardial cells is sufficient to generate an arrhythmic beat that is 
conducted in the whole heart. 
Thus in this work we provided evidence of the existence of synaptic contact between SNs 
and CMs in vitro, supported by preliminary  in vivo experiments, showing that the control 
of heart activity by sympathetic neurons occurs in fraction of time (100-150 ms) that is 
compatible to 30-50 nm of ST-to-CM distance. In addition we showed that by 
depolarizing a limited fraction of cells we were able to trigger an arrhythmic beat that is 
conducted in the whole heart, supporting the hypothesis previous described that the 
unbalanced SN impairment is a cause of an asynchronous activation of a small fraction of 
cells sufficient to trigger arrhythmic event. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
99 
 
 
 
 
100 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
101 
 
REFERENCES 
 
1. Arora, R.C., et al. (2003) Intrinsic cardiac nervous system in tachycardia induced 
heart failure. Am J Physiol Regul Integr Comp Physiol 285, R1212-23 DOI: 
10.1152/ajpregu.00131.2003. 
2. Esler M Fau - Jennings, G., et al. (1988) Assessment of human sympathetic nervous 
system activity from measurements of norepinephrine turnover. Hypertension, . 
3. Shcherbakova, O.G., et al. (2007) Organization of beta-adrenoceptor signaling 
compartments by sympathetic innervation of cardiac myocytes. J Cell Biol 176, 
521-33 DOI: 10.1083/jcb.200604167. 
4. Zhang F Fau - Wang, L.-P., et al. (2006 Oct) Channelrhodopsin-2 and optical 
control of excitable cells. Nat, Methods  
5. Zhang F Fau - Wang, L.-P., et al. (2007 Apr 5) Multimodal fast optical 
interrogation of neural circuitry. Nature, . 
6. Shimada T Fau - Kawazato, H., et al. (2004 Oct) Cytoarchitecture and intercalated 
disks of the working myocardium and the conduction system in the mammalian 
heart. Anat Rec, A. Discov Mol Cell Evol Biol  
7. Sheikh F Fau - Ross, R.S., J. Ross Rs Fau - Chen, and J. Chen ( 2009 Aug) Cell-
cell connection to cardiac disease. Trends Cardiovasc, Med. 
8. Jamora C Fau - Fuchs, E. and E. Fuchs (Nat Cell, Biol 2002 Apr) Intercellular 
adhesion, signalling and the cytoskeleton. Nat Cell,x. 
9. Yamada S Fau - Pokutta, S., et al. (2005 Dec 2) Deconstructing the cadherin-
catenin-actin complex. Cell, . 
10. Severs Nj Fau - Bruce, A.F., et al. (2008 Oct 1) Remodelling of gap junctions and 
connexin expression in diseased myocardium. Cardiovasc, Res  
11. Anderson Rh Fau - Yanni, J., et al. The anatomy of the cardiac conduction system. 
Clin, Anat. 
12. Fabiato A Fau - Fabiato, F. and F. Fabiato ( 1975 Aug) Contractions induced by a 
calcium-triggered release of calcium from the sarcoplasmic reticulum of single 
skinned cardiac cells. J. Physiol. 
13. Berridge, M.J. (2003 Oct) Cardiac calcium signalling. Biochem Soc, Trans  
14. Chen-Izu Y Fau - McCulle, S.L., et al. (2006 Jul 1) Three-dimensional distribution 
of ryanodine receptor clusters in cardiac myocytes. Biophys, J. 
15. Yatani A Fau - Codina, J., et al. (, 1987 Nov 27) A G protein directly regulates 
mammalian cardiac calcium channels. Science, . 
16. Hulme Jt Fau - Lin, T.W.C., et al. (2003 Oct 28) Beta-adrenergic regulation 
requires direct anchoring of PKA to cardiac CaV1.2 channels via a leucine zipper 
interaction with A kinase-anchoring protein 15. Proc Natl Acad Sci, U. S. A. . 
17. Reiken S Fau - Lacampagne, A., et al. ( 2003 Mar 17) PKA phosphorylation 
activates the calcium release channel (ryanodine receptor) in skeletal muscle: 
defective regulation in heart failure. J. Cell Biol. 
18. Brittsan Ag Fau - Carr, A.N., et al. (2000 Apr 21) Maximal inhibition of SERCA2 
Ca(2+) affinity by phospholamban in transgenic hearts overexpressing a non-
phosphorylatable form of phospholamban. J. Biol Chem. 
19. Hildreth V Fau - Anderson, R.H., et al. (2009 Jan 
) Autonomic innervation of the developing heart: origins and function. Clin, Anat 
102 
 
   
20. Ieda M Fau - Kanazawa, H., et al. (2007 May) Sema3a maintains normal heart 
rhythm through sympathetic innervation patterning. Nat, Med  
21. Snider, W.D. (1994 Jun 3) Functions of the neurotrophins during nervous system 
development: what the knockouts are teaching us. Cell, . 
22. Lockhart St Fau - Turrigiano, G.G., S.J. Turrigiano Gg Fau - Birren, and S.J. 
Birren (2008 Jun) Nerve growth factor modulates synaptic transmission between 
sympathetic neurons and cardiac myocytes. J. Neurosci  
23. Murad F Fau - Chi, Y.M., et al. Adenyl cyclase. III. The effect of catecholamines 
and choline esters on the formation of adenosine 3',5'-phosphate by preparations 
from cardiac muscle and liver. J. Biol Chem. 
24. Sculptoreanu A Fau - Scheuer, T., W.A. Scheuer T Fau - Catterall, and W.A. 
Catterall (1993 Jul 15) Voltage-dependent potentiation of L-type Ca2+ channels 
due to phosphorylation by cAMP-dependent protein kinase. Nature, . 
25. Yoshida A Fau - Takahashi, M., et al. (1992 Feb) Phosphorylation of ryanodine 
receptors in rat myocytes during beta-adrenergic stimulation. J. Biochem  
26. Toyofuku T Fau - Kurzydlowski, K., et al. (1993 Feb 5) Identification of regions in 
the Ca(2+)-ATPase of sarcoplasmic reticulum that affect functional association 
with phospholamban. 
27. Cao, J.M., et al. (2000) Relationship between regional cardiac hyperinnervation 
and ventricular arrhythmia. Circulation 101, 1960-9. 
28. Xiang, Y. and B.K. Kobilka (2003) Myocyte adrenoceptor signaling pathways. 
Science 300, 1530-2 DOI: 10.1126/science.1079206. 
29. Chruscinski Aj Fau - Rohrer, D.K., et al. (1999 Jun 11) Targeted disruption of the 
beta2 adrenergic receptor gene. J. Biol Chem. 
30. Bernstein D Fau - Fajardo, G., et al. (Am, J. Physiol Heart Circ Physiol 2005 Dec) 
Differential cardioprotective/cardiotoxic effects mediated by beta-adrenergic 
receptor subtypes. Am, J. Physiol Heart Circ Physiolx. 
31. Zheng M Fau - Zhu, W., et al. ( 2005 Dec) Emerging concepts and therapeutic 
implications of beta-adrenergic receptor subtype signaling. Pharmacol, Ther. 
32. Rohrer Dk Fau - Desai, K.H., et al. (1996 Jul 9) Targeted disruption of the mouse 
beta1-adrenergic receptor gene: developmental and cardiovascular effects. Proc 
Natl Acad Sci, U. S. A. . 
33. Devic, E., et al. (2001) Beta-adrenergic receptor subtype-specific signaling in 
cardiac myocytes from beta(1) and beta(2) adrenoceptor knockout mice. Mol 
Pharmacol 60, 577-83. 
34. Nikolaev Vo Fau - Moshkov, A., et al. (2010 Mar 26) Beta2-adrenergic receptor 
redistribution in heart failure changes cAMP compartmentation. Science, . 
35. Nikolaev, V.O., et al. (2006) Cyclic AMP imaging in adult cardiac myocytes 
reveals far-reaching beta1-adrenergic but locally confined beta2-adrenergic 
receptor-mediated signaling. Circ Res 99, 1084-91 DOI: 
10.1161/01.RES.0000250046.69918.d5. 
36. Meredith It Fau - Eisenhofer, G., et al. (1993 Jul) Cardiac sympathetic nervous 
activity in congestive heart failure. Evidence for increased neuronal 
norepinephrine release and preserved neuronal uptake. Circulation, . 
37. Kiuchi K Fau - Shannon, R.P., et al. (1993 Mar) Myocardial beta-adrenergic 
receptor function during the development of pacing-induced heart failure. J. Clin 
Invest  
103 
 
38. Engelhardt S Fau - Bohm, M., et al. (1996 Jan) Analysis of beta-adrenergic 
receptor mRNA levels in human ventricular biopsy specimens by quantitative 
polymerase chain reactions: progressive reduction of beta 1-adrenergic receptor 
mRNA in heart failure. J. Am Coll Cardiol 0735-1097 (Print). 
39. Ponsioen B Fau - Zhao, J., et al. (2004 Dec) Detecting cAMP-induced Epac 
activation by fluorescence resonance energy transfer: Epac as a novel cAMP 
indicator. Embo Rep  
40. Zhang J Fau - Ma, Y., et al. (2001 Dec 18) Genetically encoded reporters of 
protein kinase A activity reveal impact of substrate tethering. Proc Natl Acad Sci, 
U. S. A. . 
41. de Rooij J Fau - Zwartkruis, F.J., et al. (1998 Dec 3) Epac is a Rap1 guanine-
nucleotide-exchange factor directly activated by cyclic AMP. Nature, . 
42. Allen, M.D. and J. Zhang (2006) Subcellular dynamics of protein kinase A activity 
visualized by FRET-based reporters. Biochem Biophys Res Commun 348, 716-21 
DOI: 10.1016/j.bbrc.2006.07.136. 
43. Landis, S.C. (1976 Nov) Rat sympathetic neurons and cardiac myocytes 
developing in microcultures: correlation of the fine structure of endings with 
neurotransmitter function in single neurons. Proc Natl Acad Sci, U. S. A. 
44. Potter, D.D., et al. (1986) Synaptic functions in rat sympathetic neurons in 
microcultures. II. Adrenergic/cholinergic dual status and plasticity. J Neurosci 6, 
1080-98. 
45. Zaika, O., J. Zhang, and M.S. Shapiro (2011) Functional role of M-type (KCNQ) 
K(+) channels in adrenergic control of cardiomyocyte contraction rate by 
sympathetic neurons. J Physiol 589, 2559-68 DOI: 10.1113/jphysiol.2010.204768. 
46. Ogawa, S., et al. (1992) Direct contact between sympathetic neurons and rat 
cardiac myocytes in vitro increases expression of functional calcium channels. J 
Clin Invest 89, 1085-93 DOI: 10.1172/jci115688. 
47. Marvin Wj Jr Fau - Atkins, D.L., et al. (1984 Jul) In vitro adrenergic and 
cholinergic innervation of the developing rat myocyte. Circ, Res  
48. Conforti L Fau - Tohse, N., N. Tohse N Fau - Sperelakis, and N. Sperelakis (1991 
Apr) Influence of sympathetic innervation on the membrane electrical properties 
of neonatal rat cardiomyocytes in culture. J. Dev Physiol. 
49. Meredith, I.T., et al. (1991) Evidence of a selective increase in cardiac sympathetic 
activity in patients with sustained ventricular arrhythmias. N Engl J Med 325, 
618-24 DOI: 10.1056/nejm199108293250905. 
50. Dae, M.W., et al. (1997) Heterogeneous sympathetic innervation in German 
shepherd dogs with inherited ventricular arrhythmia and sudden cardiac death. 
Circulation 96, 1337-42. 
51. Chen, L.S., et al. (2007) New perspectives on the role of autonomic nervous system 
in the genesis of arrhythmias. J Cardiovasc Electrophysiol 18, 123-7 DOI: 
10.1111/j.1540-8167.2006.00590.x. 
52. Du Xj Fau - Cox, H.S., et al. (1999 Sep) Sympathetic activation triggers 
ventricular arrhythmias in rat heart with chronic infarction and failure. 
53. Akutsu, Y., et al. (2008) Cardiac sympathetic nerve abnormality predicts 
ventricular tachyarrhythmic events in patients without conventional risk of sudden 
death. Eur J Nucl Med Mol Imaging 35, 2066-73 DOI: 10.1007/s00259-008-0879-
x. 
104 
 
54. Paul, M., et al. (2006) Impact of sympathetic innervation on recurrent life-
threatening arrhythmias in the follow-up of patients with idiopathic ventricular 
fibrillation. Eur J Nucl Med Mol Imaging 33, 866-70 DOI: 10.1007/s00259-005-
0061-7. 
55. Keller, N.R., et al. (2004) Norepinephrine transporter-deficient mice exhibit 
excessive tachycardia and elevated blood pressure with wakefulness and activity. 
Circulation 110, 1191-6 DOI: 10.1161/01.cir.0000141804.90845.e6. 
56. Myles, R.C., et al. (2012) Local beta-adrenergic stimulation overcomes source-
sink mismatch to generate focal arrhythmia. Circ Res 110, 1454-64 DOI: 
10.1161/circresaha.111.262345. 
57. Priori Sg Fau - Napolitano, C., et al. (2002 Jul 2) Clinical and molecular 
characterization of patients with catecholaminergic polymorphic ventricular 
tachycardia. Circulation, . 
58. Priori Sg Fau - Napolitano, C., et al. ( 2001 Jan 16) Mutations in the cardiac 
ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic 
ventricular tachycardia. Circulation, . 
59. Postma Av Fau - Denjoy, I., et al. Absence of calsequestrin 2 causes severe forms 
of catecholaminergic polymorphic ventricular tachycardia. Circ Res.   
18;91(8):e21-6. 
60. Bers, D.M. (2004 Aug) Macromolecular complexes regulating cardiac ryanodine 
receptor function. J. Mol Cell Cardiol. 
61. Marx So Fau - Reiken, S., et al. (2000 May 12) PKA phosphorylation dissociates 
FKBP12.6 from the calcium release channel (ryanodine receptor): defective 
regulation in failing hearts. Cell, . 
62. Wehrens Xh Fau - Lehnart, S.E., et al. (2003 Jun 27) FKBP12.6 deficiency and 
defective calcium release channel (ryanodine receptor) function linked to exercise-
induced sudden cardiac death. Cell, . 
63. Wehrens Xh Fau - Lehnart, S.E., et al. ( 2004 Apr 2) Ca2+/calmodulin-dependent 
protein kinase II phosphorylation regulates the cardiac ryanodine receptor. Circ, 
Res. 
64. Lehnart Se Fau - Mongillo, M., et al. (2008 Jun) Leaky Ca2+ release 
channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice. J. 
Clin Invest  
65. Jiang D Fau - Xiao, B., et al. (2004 Aug 31) RyR2 mutations linked to ventricular 
tachycardia and sudden death reduce the threshold for store-overload-induced 
Ca2+ release (SOICR). Proc Natl Acad Sci, U. S. A. . 
66. George Ch Fau - Higgs, G.V., F.A. Higgs Gv Fau - Lai, and F.A. Lai ( 2003 Sep 
19) Ryanodine receptor mutations associated with stress-induced ventricular 
tachycardia mediate increased calcium release in stimulated cardiomyocytes. Circ, 
Res. 
67. Leenhardt A Fau - Lucet, V., et al. (1995 Mar 1) Catecholaminergic polymorphic 
ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation, . 
68. Nagel G Fau - Szellas, T., et al. (2003 Nov 25) Channelrhodopsin-2, a directly 
light-gated cation-selective membrane channel. Proc Natl Acad Sci, U. S. A. . 
69. Foster Kw Fau - Saranak, J., et al. (1984 Oct 2) A rhodopsin is the functional 
photoreceptor for phototaxis in the unicellular eukaryote Chlamydomonas. Nature, 
5-31. 
105 
 
70. Boyden Es Fau - Zhang, F., et al. (2005 Sep) Millisecond-timescale, genetically 
targeted optical control of neural activity. Nat, Neurosci. 
71. Arenkiel Br Fau - Peca, J., et al. (,2007 Apr 19) In vivo light-induced activation of 
neural circuitry in transgenic mice expressing channelrhodopsin-2. Neuron. 
72. Wang H Fau - Peca, J., et al. (Proc Natl Acad Sci, U. S. A.2007 May 8) High-
speed mapping of synaptic connectivity using photostimulation in 
Channelrhodopsin-2 transgenic mice. Proc Natl Acad Sci, U. S. A.x. 
73. Katzel D Fau - Zemelman, B.V., et al. ( 2011 Jan) The columnar and laminar 
organization of inhibitory connections to neocortical excitatory cells. Nat, 
Neurosci. 
74. Bruegmann T Fau - Malan, D., et al. (2010 Nov) Optogenetic control of heart 
muscle in vitro and in vivo. Nat, Methods. 
75. Bohm M Fau - La Rosee, K., et al., Evidence for reduction of norepinephrine 
uptake sites in the failing human heart. J. Am Coll Cardiol  1995 Jan(0735-1097 
(Print)). 
76. Zaglia T Fau - Milan, G., et al., Cardiac sympathetic neurons provide trophic 
signal to the heart via beta2-adrenoceptor-dependent regulation of proteolysis. 
Cardiovasc, Res 2013 Feb 1(1755-3245 (Electronic)). 
77. Shcherbakova Og Fau - Hurt, C.M., et al., Organization of beta-adrenoceptor 
signaling compartments by sympathetic innervation of cardiac myocytes. J. Cell 
Biol 2007 Feb 12(0021-9525 (Print)). 
78. Klemm M Fau - Hirst, G.D., G. Hirst Gd Fau - Campbell, and G. Campbell, 
Structure of autonomic neuromuscular junctions in the sinus venosus of the toad. J. 
Auton Nerv Syst 1992 Jun 15(0165-1838 (Print)). 
79. Bennett Mr Fau - Gibson, W.G., J. Gibson Wg Fau - Robinson, and J. Robinson, 
Probabilistic secretion of quanta: spontaneous release at active zones of 
varicosities, boutons, and endplates. Biophys, J., 1995 Jul(0006-3495 (Print)). 
80. Aravanis Am Fau - Wang, L.-P., et al., An optical neural interface: in vivo control 
of rodent motor cortex with integrated fiberoptic and optogenetic technology. J. 
Neural Eng 2007 Sep(1741-2560 (Print)). 
81. Greene La Fau - Tischler, A.S. and A.S. Tischler, Establishment of a 
noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond 
to nerve growth factor. Proc Natl Acad Sci, U. S. A., 1976 Jul(0027-8424 (Print)). 
82. Greene La Fau - Rein, G. and G. Rein, Synthesis, storage and release of 
acetylcholine by a noradrenergic pheochromocytoma cell line. Nature, , 1977 Jul 
28(0028-0836 (Print)). 
83. Nagel G Fau - Brauner, M., et al., Light activation of channelrhodopsin-2 in 
excitable cells of Caenorhabditis elegans triggers rapid behavioral responses. 
Curr, Biol 2005 Dec 20(0960-9822 (Print)). 
84. Caron Mg Fau - Lefkowitz, R.J. and R.J. Lefkowitz, Catecholamine receptors: 
structure, function, and regulation. Recent Prog Horm, , Res 1993(0079-9963 
(Print)). 
85. Zipes Dp Fau - Wellens, H.J. and H.J. Wellens, Sudden cardiac death. Circulation, 
x, 1998 Nov 24(0009-7322 (Print)). 
86. Rubart M Fau - Zipes, D.P. and D.P. Zipes (2005 Sep) Mechanisms of sudden 
cardiac death. J. Clin Invest  
106 
 
87. Huikuri Hv Fau - Castellanos, A., R.J. Castellanos A Fau - Myerburg, and R.J. 
Myerburg, Sudden death due to cardiac arrhythmias. N. Engl J Med 2001 Nov 
15(0028-4793 (Print)). 
88. Verkerk Ao Fau - Veldkamp, M.W., et al., Effects of cell-to-cell uncoupling and 
catecholamines on Purkinje and ventricular action potentials: implications for 
phase-1b arrhythmias. Cardiovasc, Res 2001 Jul(0008-6363 (Print)). 
89. Wier Wg Fau - ter Keurs, H.E., et al., Ca2+ 'sparks' and waves in intact 
ventricular muscle resolved by confocal imaging. Circ, Rest, 1997 Oc(0009-7330 
(Print)). 
90. Baader Ap Fau - Buchler, L., et al. (Res 2002 Jan) Real time, confocal imaging of 
Ca(2+) waves in arterially perfused rat hearts. Cardiovasc, Res. 
91. Tanaka H Fau - Oyamada, M., et al., Excitation-dependent intracellular Ca2+ 
waves at the border zone of the cryo-injured rat heart revealed by real-time 
confocal microscopy. J. Mol Cell Cardiol 2002 Nov(0022-2828 (Print)). 
92. Kaneko T Fau - Tanaka, H., et al., Three distinct types of Ca(2+) waves in 
Langendorff-perfused rat heart revealed by real-time confocal microscopy. Circ, 
Res 2000 May 26(1524-4571 (Electronic)). 
93. Wikswo Jp Jr Fau - Lin, S.F., R.A. Lin Sf Fau - Abbas, and R.A. Abbas, Virtual 
electrodes in cardiac tissue: a common mechanism for anodal and cathodal 
stimulation. Biophys, J. x, Biophys, J. 1995 Dec(0006-3495 (Print)). 
94. Campbell Rw Fau - Murray, A., D.G. Murray A Fau - Julian, and D.G. Julian, 
Ventricular arrhythmias in first 12 hours of acute myocardial infarction. Natural 
history study. Br Heart, J. , 1981 Oct(0007-0769 (Print)). 
95. Adgey Aa Fau - Devlin, J.E., et al. (1982 Jan) Initiation of ventricular fibrillation 
outside hospital in patients with acute ischaemic heart disease. 1982 Jan. 
96. Johnston Km Fau - MacLeod, B.A., M.J. MacLeod Ba Fau - Walker, and M.J. 
Walker, Responses to ligation of a coronary artery in conscious rats and the 
actions of antiarrhythmics. Can, J. Physiol Pharmacol 1983 Nov(0008-4212 
(Print)). 
 
 
